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Abstract
Heavy menstrual bleeding (HMB) is a well-recognized health issue among women of
reproductive age. The characteristics and demographics of women in the community with
HMB who present at the emergency department (ED) are not well described. This
research aimed to describe the cohort of women who seek treatment at the ED. The
Healthcare Cost and Utilization Project 2016 National Emergency Department Sample
was examined. The theory of reasoned action predicts that women who present at the ED
are exhibiting health seeking behavior. From 32 million records, the inception cohort
identified N = 111,555 cases. Using national estimation weights, this translates to
approximately 509,833 ED visits in the United States for HMB. The majority of the
cohort, 39.59%, came from the lowest median household income quartile by ZIP code
(under $42,999). Women with anemia were significantly older than the overall cohort.
The greatest incidence of anemia was in women aged 40 to 49 years, 7.41%. Four logistic
regression models examining the whole cohort and three comorbidities (anemia,
hypertension, and diabetes) found age to be a significant predictor of hospitalization. Low
income was also a significant predictor of hospitalization. The proportion hospitalized in
the lowest household income group was significantly greater versus each of the other
three quartiles, p < 0.001. Women living in the rural locations with the lowest household
income had the highest proportion of hospitalizations. Women of economic disadvantage
are most likely to use the ED for medical care. Residing in rural areas may lead to health
avoidance until the severity of symptoms necessitates hospitalization. These findings
signify a silent public health burden.
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Chapter 1: Introduction to the Study
Introduction
Menorrhagia, or heavy menstrual bleeding (HMB), represents the most common
gynecological presentation in women of reproductive age (Davis & Kadir, 2017).
Consultation with specialist care characterizes ideal healthcare. Individuals lacking health
care (insurance) access, who live in remote or rural areas, or who do not understand the
potential long-term consequences may then use other healthcare sources, such as the
emergency department (ED). Excessive or heavy bleeding has historically been defined
as a daily blood loss of greater than 80 mL per menstrual cycle (Hallberg & Nilsson,
1964). This criterion, while measurable, is extremely difficult and impractical to quantify
in clinical practice or an ambulatory setting. This quantification measure makes the
estimation of HMB somewhat subjective and dependent on the history provided by the
patient. The health impact attributed to HMB may affect several aspects of a woman’s
life. Negative impacts on a woman’s overall quality of life (QoL) have been observed
(Weisberg et al., 2016). Key aspects including overall mood, level of energy, productivity
at work and school, social interactions, daily family life, and sexual functioning are often
negatively affected (Hasselrot et al., 2018). The association between blood loss and QoL
appears to be directly related (Bruinvels et al., 2016). Women who thus present in the ED
may believe that their problem can only be treated in an ED (Dyne & Miller, 2019).
Repeated ER visits and hospital admission may represent more severe forms of HMB or
reflect other health characteristics (Birmingham et al., 2017). However, the
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characteristics of women who use the ED for HMB are not well described in the
literature.
Estimates of prevalence vary. Life stage characteristics such as parity have not
been frequently studied (Rocha et al., 2018). In the United Kingdom, 5% of women aged
between 30 and 49 years consult their primary care physician each year with HMB
(Davis & Kadir, 2017). However, the health impact of HMB may be substantive. Fraser
et al. (2015) reported on reproductive health in a European-wide internet-based
population survey conducted in five representative European countries among 4,506
women (aged 18–57 years). They found that two or more HMB symptoms were reported
in 1,225 (27%) of the women (Fraser et al., 2015). Within this cohort, 661 (27%) of the
women sought medical attention at least once a year (Fraser et al., 2015). Iron deficiencyassociated symptoms were frequent, and previous confirmed diagnosis or treatment for
iron deficiency anemia occurred in 63% of the women surveyed (Fraser et al., 2015).
Fraser et al. (2015) reported a frequency of HMB within the community of
between 30 to 40%. They also observed that age appears to be important, with younger
populations reporting slightly higher rates (Fraser et al., 2015). A prevalence rate of 40%
was reported in an adolescent population of women aged 12 to 18 (Rocheleau et al.,
2017). In a community-based cross-sectional descriptive survey on a randomized sample
of the Swedish general population, investigators found a prevalence rate of 32% of
women experiencing HMB (Karlsson et al., 2014). This study included an older cohort of
1,547 women, aged 40 to 45 years old. In addition to HMB, they reported that in general,
menstrual bleeding was associated with negative perceptions and limited social and
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professional activities (Karlsson et al., 2014). These negative perceptions affected several
QoL domains, especially body pain (p < 0.0001) in the Short Form-36v2 (SF-36). These
health-related quality of life (HRQoL) scores were significantly more affected in women
experiencing HMB than those with normal menstrual bleeding patterns (Karlsson et al.,
2014). The Short Form-36v2 SF-36 showed that women experiencing HMB had
significantly worse HRQoL compared with women with normal menstrual bleeding in all
domains (Karlsson et al., 2014).
Among health indicators of importance, HMB is recognized as a problem
suspected to be underreported (Hacioglu et al., 2016). Excessive menstrual bleeding is
often difficult to quantify and assess (Gursel et al., 2014). Menorrhagia is thus often
characterized as an unexplained bleeding event. These sentinel events of reproductive
health may consequently serve as a predictor and surrogate marker of an underlying
defect such as an undetected bleeding disorder or platelet defect (Rajpurkar et al., 2016).
In early reproductive life, unattended bleeding disorders may have a profound effect on
health and well-being (Dowlut-McElroy et al., 2015). Understanding the incidence and
characterizing risk factors associated with these events may lead to improved public
health awareness of women’s health needs in the community.
The impact of HMB on health status and QoL may fluctuate during reproductive
years. In the United States, hysterectomy before age 60 occurs in one-third of women
(Whiteman et al., 2008). Heavy bleeding associated with uterine leiomyoma,
endometriosis, and uterine prolapse is the most common associated symptom. A
retrospective 2003 study of inpatient admissions included 300,359 women who were
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hospitalized for excessive bleeding symptoms had a mean age of 42 years (Morrison et
al., 2008). Women between 25 to 50 years represented 85% of the study population.
Adolescents, who were defined as women between 12 to 24 years of age, contributed 2%
of the study cohort. These women in the youngest age group were 7.25 times (p < 0.001)
more likely to present with anemia versus not. Additionally, African American and
Hispanic women had disproportionate anemia frequencies versus White women
(Morrison et al., 2008). Overall, 25% of the in-patient women had anemia.
A global survey of 1,032 health care providers revealed that 61% of women with
HMB had no causal coagulopathy (Rocha et al., 2018). These trends support the
hypothesis that many women do not appreciate the consequences of excessive menstrual
bleeding and most likely do not seek help before this event, leading to health
consequences. Additionally, in public health, the role of place is recognized as important.
Finkelstein et al. (2017) found that differences in where Medicare enrollees reported their
diagnoses to occur reflect not only differences in their diagnosis but differences in the
quality of their underlying health. Understanding the association between proximity to
the ED and severity of symptoms (captured by admission rates) may estimate disparities
with the population.
Understanding the risk factors, comorbidities, and spatial factors associated with
ED menorrhagia events have not been assessed in a population setting. Unattended
excess bleeding events during reproductive years may lead to a reduced general QoL and
lower psychosocial wellbeing (Philipp et al., 2011). Chronic blood loss can lead to an
anemic state. Left unrecognized and untreated, anemia may compound QoL decrement
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by contributing to poor school performance, increased rates of absence from school, and
avoidance of physical activity (Kassebaum et al., 2014). Excess days lost from work,
lifestyle disruptions, and increased health care costs have also been described (James et
al., 2006). Recognition of HMB in early reproductive life may reduce the associated
health-related consequences and potentially allow for the management of modifiable
contributing factors. Presentation of such events is suspected to take place in EDs
(Livesey et al., 2016). To date, no researchers have described the risk characteristics of
women in the community who seek attention in the ED for HMB (Rocha et al., 2018).
Identifying comorbidities, risks, the contribution of insurance status, and location is not
well described Therefore, there is a gap in knowledge of demographic data,
comorbidities, and proximity to health care. In this study, I focused on the problem of
HMB risk factors not associated with a coagulation defect to address this gap.
Problem Statement
Menorrhagia, or HMB, represents the most common gynecological presentation
in women of reproductive age (Davis & Kadir, 2017). Consultation with specialist care
represents ideal healthcare (Kiran et al., 2018). Individuals lacking health care
(insurance) access, who live in remote or rural areas, or who do not understand the
potential long term consequences may then use other urgent healthcare access such as the
ED (Sardo et al., 2016). Excessive or heavy bleeding has historically been defined as a
daily blood loss of greater than 80 mL per menstrual cycle (Hallberg & Nilsson, 1964).
This criterion, while measurable, is extremely difficult to quantify in practice (Quinn &
Higham, 2016). This quantification measure makes the estimation of HMB somewhat
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subjective and dependent on the history provided by the patient (Herman et al., 2016).
The health impact attributed to HMB may affect several aspects of a woman’s life
(Karlsson et al., 2014). Negative impacts on a woman’s overall QoL have been observed
(Weisberg et al., 2016). Key aspects including overall mood, level of energy, productivity
at work and school, social interactions, daily family life, and sexual functioning are often
negatively affected (Hasselrot et al., 2018). The association between blood loss and QoL
appears to be directly related (Bruinvels et al., 2016). Women who thus present in the ED
may be demonstrating certain health-seeking behavior and believe their problem can only
be treated in an ED (Rocha et al., 2018). Repeated ER visits and hospital admission may
represent more severe forms of HMB or reflect other health characteristics (Birmingham,
et al., 2017). The characteristics of women who use the ED for HMB are not well
described in the literature.
Estimates of HMB prevalence vary. Life stage characteristics such as parity have
not been frequently studied (Rocha et al., 2018). In the United Kingdom, 5% of women
aged between 30 and 49 years consult their primary care physician each year with HMB
(Davis & Kadir, 2017). The health impact of HMB may be substantive. Fraser et al.
(2015) reported on reproductive health in a European-wide internet-based population
survey conducted in five representative European countries among 4,506 women (aged
18–57 years). They found that two or more HMB symptoms were reported in 1,225
(27%) of the women (Fraser et al., 2015). Within this cohort, 661 (27%) of the women
sought medical attention at least once a year (Fraser et al., 2015). Iron deficiency
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associated symptoms were frequent; previous confirmed diagnosis or treatment for iron
deficiency anemia occurred in 63% of the women surveyed (Fraser et al., 2015).
Fraser at al. (2015) reported a frequency of HMB within the community of
between 30 to 40%. They also observed that age appears to be important, with younger
populations reporting slightly higher rates (Fraser et al., 2015). A prevalence rate of 40%
was reported in an adolescent population of women age 12 to 18 (Rocheleau et al., 2017).
In a community-based cross-sectional descriptive survey on a randomized sample of the
Swedish general population, investigators found a prevalence rate of 32% of women
experiencing HMB (Karlsson et al., 2014). This study included an older cohort of 1,547
women, aged 40 to 45 years old (Karlsson et al., 2014). In addition to HMB, they
reported that in general, menstrual bleeding was associated with negative perceptions and
limited social and professional activities (Karlsson et al., 2014). These negative
perceptions affected several QoL domains, especially body pain (p < 0.0001) in the SF36 (Karlsson et al., 2014). These HRQoL scores were significantly more affected in
women experiencing HMB than those with normal menstrual bleeding patterns (Karlsson
et al., 2014). The Short Form-36v2 SF-36 revealed that women experiencing HMB had
significantly worse HRQoL compared with women with normal menstrual bleeding in all
domains.
The impact of HMB on health status and QoL may fluctuate during reproductive
years. In the United States, hysterectomy before age 60 occurs in one-third of women
(Whiteman et al., 2008). Heavy bleeding associated with uterine leiomyoma,
endometriosis, and uterine prolapse is the most common associated sign (Munro et al.,

8
2011). A retrospective 2003 study of inpatient admissions included 300,359 women who
were hospitalized for excessive bleeding symptoms had a mean age of 42 years
(Morrison et al., 2008). Women between 25 to 50 years represented 85% of the study
population. Adolescents who were defined as women between 12 to 24 years of age
contributed 2% of the study cohort. These women in the youngest age group were 7.25
times (p < 0.001) more likely to present with anemia versus not. Additionally, African
American and Hispanic women had disproportionate anemia frequencies versus White
women (Morrison et al., 2008). Overall, 25% of the in-patient women had anemia. A
global survey of 1,032 health care providers found that 61% of women with HMB had no
causal coagulopathy (Rocha et al., 2018). These trends support the hypothesis that many
women do not understand the consequences of excessive menstrual bleeding and most
likely do not seek help before this event, leading to health consequences. Additionally, in
public health, the role of place is recognized as important. Finkelstein et al. (2017) found
that differences in where Medicare enrollees reported their diagnoses to occur reflect not
only differences in their diagnosis but differences in the quality of their underlying
health. Understanding the association between proximity to the ED and severity of
symptoms (captured by admission rates) may estimate disparities with the population.
Understanding the economic risk factors, potential comorbidities, and location
factors associated with ED menorrhagia events have not been assessed in a large
population setting. Unattended excess bleeding events during reproductive years may
lead to reduced general QoL and lower psychosocial wellbeing (Philipp et al., 2011).
Chronic blood loss can lead to an anemic state. Left unrecognized and untreated, anemia

9
may compound QoL decrement by contributing to poor school performance, increased
rates of absence from work or school, and avoidance of physical activity (Kassebaum et
al., 2014). Excess days lost from work, lifestyle disruptions, and increased health care
costs have also been described (James et al., 2006). Recognition of HMB in early
reproductive life may reduce the associated health-related consequences and potentially
allow for the management of modifiable contributing factors. Presentation of such events
is suspected to take place in EDs (Livesey et al., 2016). To date, no researchers have
described the risk characteristics of women in the community who seek attention in the
ED for HMB (Rocha et al., 2018). Identifying comorbidities, risks, the contribution of
insurance status, and location is not known. Therefore, there is a gap in knowledge of
demographic data, comorbidities, and proximity to health care. In this study, I focused on
the problem of HMB risk factors not associated with a coagulation defect to address this
gap.
Purpose of the Study
Increased gains in population longevity in developed nations have shifted the
focus of public health from communicable disease mortality to morbidity concerns. The
concept of adding life to years versus years to life now is of equal importance (Teutsch &
Fielding, 2013). Public health research today needs to be concerned with morbidity
reduction, functional capacity gains, and disparity reduction. HMB that is ignored or
misdiagnosed for a prolonged duration may contribute to preventable morbidity. The
consequences of menorrhagia include anemia, chronic fatigue, and decreased
psychosocial wellbeing (Kassebaum et al., 2014). EDs are often the first point of medical
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contact and may function as a health sanctuary for those with limited healthcare access or
for those who have ignored bleeding symptoms (Livesey et al., 2016). ED presentation
for menorrhagia may indicate that an individual has exceeded a tolerance threshold
(Sriprasert et al., 2017). Those without access to gynecological services may be at
increased risk for secondary health issues. Characterizing the incidence and risk factors
for women who present at the ED with HMB symptoms is not well known. Quantifying
risk factors associated with presentation, including race, age, comorbidities such as
diabetes, hypertension, or metabolic challenges remain unexplored. Additionally, hospital
admission rates could further help quantify the severity of inadequate care suspected to
be the result of limited access to gynecological attention (Demers et al., 2006).
Research Questions and Hypotheses
In this project, I tested the hypothesis that disparities may exist within the
community for women who experience HMB. ED presentation for HMB may indicate
that an individual has exceeded a tolerance threshold (Sriprasert et al., 2017). A
consequence of delayed medical attention may be an increased risk for secondary health
issues and reduced QoL. Characterizing the incidence and risk factors for women who
present at the ED with HMB symptoms is not well known. Quantifying risk factors
associated with presentation, including race, age, comorbidities such as diabetes,
hypertension, or metabolic challenges, remain unexplored.
The research questions (RQ) in this study were as follows:
RQ1: What is the association between demographic (age), health status (anemia),
insurance status, and ED presentation for HMB?
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H01: There is no statistically significant association between demographic factors
(age), health status (anemia) insurance status, and presentation to the emergency room for
women of reproductive age in the United States.
Ha1: There is a statistically significant association between demographic factors
(age), health status (anemia) insurance status, and presentation to the emergency room for
women of reproductive age in the United States.
RQ2: What is the association between health factors (comorbidities such as
diabetes and hypertension), admission for menorrhagia, and ED presentation for HMB?
H02: There is no association between health factors (comorbidities such as
diabetes and hypertension) and presentation to the emergency room for women of
reproductive age in the 37 states participating in the Nationwide Emergency Department
Sample (NEDS) in the United States.
Ha2: There is an association between health factors (comorbidities such as
diabetes and hypertension) and presentation to the emergency room for women of
reproductive age in the 37 states participating in the NEDS in the United States.
RQ3: What is the association between location and economic status (see Song et
al. 2010) and ED presentation for HMB?
H03: There is no association between location and economic status and
presentation to the emergency room for women of reproductive age in the United States.
Ha3: There is an association between location and economic status and
presentation to the emergency room for women of reproductive age in the United States.
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Theoretical Framework for the Study
The framework for this research is the theory of reasoned action (TRA). Fishbein
and Ajzen (1975) proposed the TRA. They postulated that an essential predictor of
behavior (i.e., what a person actually does) is their behavioral intention (i.e., a person’s
intention to perform or not perform the behavior) (Fishbein & Azjen, 1975). Behavioral
intention can be considered a joint function of a person’s approach toward performing the
behavior and subjective norms (Didarloo et al., 2012). Seeking attention for HMB
depends on both the attitude of the health-seeking individual and the influence of what
they perceive to be normal bleeding. The TRA would thus predict that seeking medical
attention at the ED is driven by a perception of a health crisis (see Glanz et al., 2008).
The TRA highlights the prominence of intention as a determinant of behavior.
Contributing to intention is the individual attitude towards the health issue and the
perception of what constitutes normal menses. In the setting of HMB, individual
determination of heavy menses patterns that constitute a clinically defined excessive
bleeding pattern is theorized to be complex. If an individual relies on a direct relative for
bleeding pattern context, they potentially run the risk of referencing a family member
who may express the same phenotype and who may also not demonstrate a healthseeking behavior. Thus, a comparison of this health status indicator against an individual
from the same genetic pedigree (related family member) results in a biased reference
discordant from normal (see Kujovich, 2005). The TRA postulates that perceptual
awareness and action are independent determinants of behavioral intention. Individuals
who seek medical attention from the ED may be displaying health-seeking behaviors and

13
be recognizing that their menstrual bleeding patterns deviate from a perceptual norm
(Roberto et al., 2011). ED presentation would thus suggest that the unattended bleeding
patterns are serious in nature and that the woman is exhibiting a concern for personal
well-being.
Nature of the Study
Understanding the determinants of menorrhagia and unexplained bleeding
requires an in-depth knowledge of the complex interactions of genomic, biological,
clinical, lifestyle, and societal factors (Lauer, 2012). Cohort studies have helped
researchers to better understand the complex etiology of many diseases, such as cancer
and cardiovascular disease (Kennedy et al., 2016). Such approaches have allowed
epidemiologists to develop risk prediction analyses and models to improve public health
guidelines for prevention and provide evidence for health policies.
Evidence supports the theory that HMB may be associated with negative
perceptions and reduced social and professional activities (Karlsson et al., 2014). This
impact on health-related QoL may have an enduring effect (Weisberg et al., 2016).
Women in the later phases of reproductive life have reported significant reductions in
HRQoL (El-Nashar et al., 2010). QoL assessment by the generic SF-36 v2 tool revealed
that all domains were significantly more affected in women experiencing HMB versus
those experiencing normal menstrual bleeding patterns. In a cohort of 1,547 Swedish
women, aged 40 to 45 years old, one-third (32%) were classified as having HMB
(Karlsson et al., 2014). This would suggest that the prevalence and impact on overall
health in the general population might be underappreciated.
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This was a retrospective quantitative study. Binary (or binomial) logistic
regression was used. This method is a form of regression used when the dependent
variable is a dichotomy and the independent variables are of any type. Employing
generalized linear modeling allowed the creation of a regression model with any
distribution of the dependent (e.g., binomial, multinomial, ordinal) and any link function
(e.g., log for log-linear analysis, logit for binary or multinomial logistic analysis,
cumulative logit for ordinal logistic analysis; see Forthofer et al., 2007). Logistic
regression can be used to predict a categorical dependent variable based on continuous
and/or categorical independents to determine the effect size of the independent variables
on the dependent, to rank the relative importance of independents, to assess interaction
effects, and to understand the impact of covariate control variables. The impact of
predictor variables is usually explained in terms of odds ratios.
Definitions
Women of reproductive age with the diagnosis of HMB were included in the
study sample. Women below the age of 10 and above 65 were excluded on the basis that
excessive uterine bleeding is due to causes other than those associated with reproductive
functioning (see Herman et al., 2016). HMB was defined by the International
Classification of Diseases (ICD) code recorded on admission. This is a patient-reported
event that may be prone to patient bias. The reliability of self-reported HMB is accepted
in the literature, as direct quantification is both time consuming (days) and unrealistic in
practice (Davis & Kadir, 2017). Coded events were thus assumed reflective of excessive
bleeding.
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Log-linear regression models were created to assess risk for severe morbidity with
risk ratios and associated 95% CI as measures of effect. Several independent (predictor)
variables were assessed. These variables were part of the patient record, and their
definitions were expected to be reliable. The reporting of race had challenges. Ethnicity
and race are used interchangeably in population research. These terms incorporate several
important factors, including linguistic, cultural, biological, and geopolitical factors
(Sankar & Cho, 2002). Thus, race and ethnicity, while potentially synonymous, may be
interpreted differently. Despite the interest in race, race was self-reported and referred to
the woman’s person’s physical appearance, such as skin, color and eye color (see Mersha
& Abebe, 2015). As ascertaining ancestral background was not possible in this study,
racial classification, when available, was assumed to reflect each woman’s preferred
racial identity (Cooper et al., 2018).
Women aged 10 to 64 years with a diagnosis of HMB (metrorrhagia,
menometrorrhagia, and polymenorrhoea) were included in the analysis. The first
exposure (RQ1) evaluated self-reported demographic variables: age (<19, 20-29, 30-39,
40-49, 50-59, and >60 years of age), health status (anemia), insurance status (Medicare,
Medicaid, private, uninsured, or other), income for zip code (ZIP code income quartile),
and patient residence (large central metro, large fringe metro [suburbs], medium and
small metro, micropolitan and noncore [rural], plus missing). The second exposure (RQ2)
assessed the presence of health-related factors, including diabetes and hypertension.
Severity of presentation was dichotomized as admission to hospital or not, and if a
subject received a transfusion or not. The third association (RQ3) evaluated the patient
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location and economic status. The national readmissions database (NRD) database
captured NEDS subjects who were subsequently admitted to hospital.
Assumptions
Large population studies with HMB have not been performed to date.
Stratification and quantification of risk factor association also remain poorly described or
unknown. Recent literature has supported the premise that unexplained menstrual
bleeding may be a poorly appreciated event. The secondary data collected from ED
presentation was theorized to represent the population who has either experienced
chronic bleeding patterns that finally trigger a behavioral change or an acute event that
triggered concern and the need for rapid attention. The collected case reports did not
distinguish between these two histories. A surrogate marker of prolonged bleeding
history is the presence of anemia (Nelson & Ritchie, 2015). This marker was used as part
of a severity index. The severity of HMB was assumed via two dimensions, hospital
admission and receiving anemia therapy, including a transfusion.
The primary outcome of this research project is the characterization of risk factors
associated with ED presentation for HMB. Increasing HMB severity is theorized to
represent poor health-seeking behaviors. An important determinant includes access to
health care. The type of insurance or absence was assumed to represent a partial marker
of socioeconomic and financial status, including employment. While insurance status as a
socioeconomic measure is limited in robustness, an absence was assumed to reflect
unemployment or minimal income attainment.
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Scope and Delimitations
In this research, I attempted to identify characteristics and comorbidities
associated with HMB presentation in the ED. Exploring location and socioeconomic
determinants may also provide evidence for disparities in the community. National
estimates were generated from the secondary data, which helped frame the scope of any
disparities identified. I did not explore an association between exposure and HMB.
Confounding by extraneous effects such as age and other factors was stratified and
adjusted for. Confounding by indication and severity was addressed. The presence of
associated symptoms (indication) was the selection criterion for inclusion. The severity of
symptoms represented a stratum that the ICD codes were not able to categorize. In this
study, I used the criterion of hospital admission as a surrogate for either severe symptoms
requiring additional complex management or a compromised health state that required
additional support. In either case, hospital admission from the ED was classified as a
severe health state.
The generalizability of the findings will be established from the study population.
The primary concern was how representative the sample was. Subjects who seek
attention in the ED are theorized to have severe symptoms, prompting health-seeking
action. This population may not be representative of individuals who have access to
gynecological care and would thus be managed in a physician’s office. The secondary
databases assessed did not capture such visits. These HMB visits collected in the
admission and hospitalization databases were limited to those seeking attention in an ED.
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The study sample thus represented the more serious or troublesome conditions and not
the mild conditions.
Limitations
An important limitation and threat to validity are using data for research purposes
for which they are not specifically generated (Kuriyama et al., 2017). Secondary data
collected from external sources have this inherent limitation. The data used were
dependent on the rigor and accuracy of the collection methods. There were limited
options to ensure inaccuracies. One check was on gender. Men reported to be diagnosed
with HMB were excluded, as well as the use of age boundaries to exclude exceptional
medical conditions. A central element of the validity of these research findings was the
accuracy of the disease status. Electronic records in HCUP that use on a categorical code
such as the ICD-10-CM/PCS or ICD-9CM are reliable. Studies that have compared
diagnoses and procedures reported in administrative data compared with medical records
have found acceptable levels of agreement (Casey et al., 2016). With secondary data, the
finding should lead to further hypothesis generation that should be prospectively tested
with primary data studies.
Significance
Due to the periodic hemostatic challenge of menses, women are particularly
susceptible to the effects of a hemostatic defect and are consequently more frequently
identified through the presentation of heavy bleeding symptoms (Kujovich, 2005).
Women of reproductive age are expected to carry a disproportionate health burden.
During reproductive years, menorrhagia that is left untreated may lead to an avoidable
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health burden (Clark & Cooper, 2016). Unrecognized anemia may contribute to poor
educational attainment (Stauder et al., 2018). An additional consequence is an elevated
risk for postpartum hemorrhage (James et al., 2011).
This research was designed to characterize the incidence of menorrhagia events
and explore potential associated risk factors in a population study. Such community
information is not available. Menorrhagia may be due to multiple causes, including
hormonal imbalances (Moon et al., 2017), pathological conditions (Brenner, 1996), and
hemostatic defects (Dilley et al., 2001). The likelihood of definitive diagnosis in the ED
is low, and outcomes associated with ED presentation are mixed.
This public health burden may be responsive to improvements in incidence
estimation and risk characterization. The potential findings may contribute to social
change in several ways. Social change in its most complete form has several dimensions.
It promotes equity, social justice, self-knowledge, service, and collaboration (Read et al.,
2016). This research contributes to the risk estimation and characterization of heavy
menstrual disease in women who use the ED for their health care.
Summary
Women’s health challenges are often underappreciated in public health. Characterization
of comorbidities and risk factors associated with HMB when presented in the ER may
increase awareness and stimulate improvements in care. Understanding factors that
contribute to hospital admission may be both medically end economically important. A
goal of this project is to provide evidence that can lead to a reduction of the health burden
of women experiencing HMB.

20
Chapter 2: Literature Review
Introduction
In a systematic review of the literature, I identified gaps in the setting where
women present to health care providers, the duration of HMB before being presentation,
and the presence of comorbidities that may contribute to risk for bleeding events. HMB is
a frequently occurring event that is estimated to affect one-quarter of women of
reproductive age (Kiran et al., 2018). Such a high prevalence in the community would
suggest that a considerable health burden exists within the population. In the United
Kingdom, 5% of women between ages 30 and 49 years consult their primary practitioner
annually for HMB (Cooper et al., 2014). These consultations result in approximately onethird of all gynecology referrals (Davis & Kadir, 2017). However, there is significant
regional variation in outcomes and surgical management resulting from these referrals
(Sayburn, 2014). These findings support the theory that health-seeking behaviors
combined with local health provider resources may be important determinants of
healthcare outcomes and general well-being during reproductive years.
Literature Search Strategy
I conducted an on-going weekly literature search using MEDLINE (PubMed) and
Embase to identify recent original English language articles published in peer-reviewed
journals. Recent articles were retrieved and assessed for relevance to the research
questions. This does not preclude seminal papers in the field that may have been
published beyond a decade ago. The search algorithm was heavy menstrual disease AND
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menorrhagia AND emergency department OR adolescent OR adult OR bleeding
disorder OR unexplained bleeding.
Theoretical Foundation
A theory is a collection of interrelated conceptual ideas, descriptions, and
schemes to systematically understand events through postulating connections among
inputs to either explain observations or predict future events (Brownson et al., 2018).
Fishbein and Ajzen (1975) proposed the TRA to potentially reconcile an individual’s
behavioral intention and their actual actions. This theory proposes that sociodemographic
variables are an important determinant in contributing to behavioral intention and action
(Esmaeili et al., 2016). The framework theorizes that individual behavioral intention is
influenced by a dynamic interaction between beliefs, attitudes, subjective norms, and the
value(s) attached to an attribute or behavioral outcome (Evans et al., 2009). The TRA
further proposes that individual behavioral choices are composed of the three important
dimensions: (a) intention, (b) attitude, and (c) subjective norms (Hansson & Rasmussen
2014). Due to subjective norms and potentially attitude, women who present in the ED
because of heavy bleeding symptoms are thus theorized to have delayed health-seeking
behaviors. This behavioral action is thus expected to be associated with more profound
anemia and related symptoms.
The contributions of subjective norms are theorized to be important. Significant
and relevant others are likely to include close family members with a similar genetic
pedigree such as mothers, aunts, and sisters. The contribution of subjective norms can be
significant. In a study assessing the contributions of TRA components, Roberto et al.
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(2011) found a significant association as a behavioral predictor. Using zero-order
correlations, the coefficient between social norms and behavioral intention was
substantial, β = 0.34, p (.26 ≤ β ≤ .42) = .95. This supports the hypothesis that potentially
obvious symptoms could be ignored due to family and subjective norms. Socioeconomic
factors may also contribute to household norms that may further compound delays in
health-seeking behaviors.
The influence of health perceptions was also expected to be meaningful. A crosssectional study using convenience sampling of 137 African American adults regarding
testing for Hepatitis C found that several dimensions for the TRA contributed to the
likelihood of testing being initiated (Rashrash et al., 2017). Several study findings are
important. First, there is an increased odd of intention to initiate health-seeking behavior
(i.e., to initiate testing for hepatitis C virus) for subjects with higher subjective norms
scores (OR = 1.42, 95% CI: 1.12–1.79). Also, perceived severity scores (OR = 1.39, 95%
CI: 1.17–1.65) and perceived benefit scores (OR = 1.57, 95% CI: 1.13–2.18) were
significant predictors of health initiation behavior (Rashrash et al., 2017). Additionally,
individuals who had a previous blood transfusion (OR = 8.25, 95% CI: 2.02–33.61) are
highly likely to seek testing. This suggests that previous exposure to the health care
system is expected to drive behavioral intention.
Using secondary data does not allow for a direct assessment of behavioral
intention or subjective norms. This theory was indirectly tested by using surrogate
markers for health-seeking behavior and subjective norms. The contribution of
sociodemographic variables was also expected to suggest differences in action (see
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Didarloo et al., 2012). Admission rates from the ED (a severity index)and the presence of
severe anemia would indicate a substantial delay in health-seeking behavior. Both
intention and subjective norms were expected to contribute to ED presentation. The
association between self-efficacy and intention has been shown to be strong (Didarloo et
al., 2011). I assumed that individuals are more likely to initiate a health-seeking behavior
when their subjective norms delay appropriate attention and conflict with how they feel
or perceive their health.
Conceptual Framework
A variety of structural and cultural factors are theorized to act as barriers leading
to women with HMB ignoring symptoms until a tipping point is reached. Presentation at
the ED represents a reduced health state where attention is being sought. Lee et al. (2014)
developed a conceptual framework to address structural and cultural barriers by an ethnic
community to health-seeking behaviors. Guided by the TRA, a conceptual framework to
this research study was proposed, see Figure 1. Barriers to addressing health needs may
include access to primary or specialized health care from inadequate or limited health
insurance, rural locations, not having access to academic or specialized care, and low
income or socioeconomic limitations. Cultural barriers may include familial phenotypes
guiding perceived norms, cultural modesty, and embarrassment as well as the fear of
potential causes.
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Figure 1
A Conceptual Framework for ED Presentation of HMB.

The conceptual framework suggests that characterizing barriers and motivators to
seeking health care could potentially lead to a better understanding of who might be at
increased risk for HMB. The research findings could guide public health awareness,
reduce the likelihood of lifelong burden, as well as update the medical community. A
better understanding of who may at increased risk, especially within geographic and
socioeconomic groups, provides evidence for the need to reduce disparities. Using this
framework supported the research focus of assessing individual comorbidities,
demographic characteristics, socioeconomic factors, and place as determinants of HMB
risk.
My goal was to determine how to describe HMB severity subtypes that may be
distinct. Understanding how ED presentation is influenced by upstream determinants
requires a stratification or estimation of severity upon presentation at the hospital and the
subsequent health corrective actions initiated. This phenotypic heterogeneity was based
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necessarily on the concept of risk heterogeneity because risks were expected to vary
among different members of the population (see Begg et al., 2013). The severity was
defined by the presence or absence of anemia and the corrective steps taken, including
admission to the hospital. These severity stratifications were then used to estimate the
contribution of predictor (independent) variables to risk, Figure 2.
Figure 2
The Conceptual Interplay of Phenotype and Broad ED Characteristics

Literature Review on Key Variables or Concepts
Menorrhagia or HMB represents the most common gynecological presentation in
women of reproductive age (Davis, 2017). Improvements in the health profile of the
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developed nation’s populations during the last several decades have resulted primarily
from public health-based changes aimed at the social, dietary, and material environment.
These changes have been driven to some extent by improved sanitation and other
deliberate public-health interventions (McMichael & Beaglehole, 2000). However, the
improvements in longevity in the most developed nations are diminishing. Health care
systems are increasingly focusing on reducing morbidity. These efforts have been
described as “putting more life in one’s years than years in one’s life” (Teutsch &
Fielding, 2013, p 287).
Health and well-being are complex concepts to define. The impact of chronic
blood loss is well documents (Kassebaum, et al., 2014). The National Institute for Health
and Care Excellence (NICE), in 2007 defined heavy menstrual bleeding to be the
associated consequences of excessive blood loss during menses. The health effect of
persistent and frequent HMB episodes is described as a health state which interferes with
a woman’s physical, emotional, social, and material quality of life, and which can occur
alone or in combination with other symptoms (NICE, 2007). An important public health
goal is to improve the health of populations (Erwin & Brownson, 2017). To improve
health among women with HMB understanding and characterizing risk factors as well as
demographic epidemiology will be important. Additionally, the distribution of burden
within the community is also not well understood.
When primary care services are not available, alternative options are expected to
become necessary. An important alternate health care resource frequently utilized is the
emergency department (Sardoet et al., 2016). When women perceive their menstrual flow
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to be heavy or excessive, they are theorized to be more likely to seek medical care.
Evidence shows that women who perceive that their menstrual flow as heavy utilizes
more health care resources than women with a light flow, OR = 1.45 (95% CI: 1.02-2.05)
(Cote et al., 2001). Emergency department utilization was even more pronounced OR
1.79 (95% CI: 1.36-2.37). The most prominent contributors to mortality and morbidity
globally and in the United States are behavioral factors (Glanz & Bishop, 2010). Seeking
health care for HMB in an ER setting suggests that these women may be a different and
varied population within the community. Characterizing comorbidities, the burden of
disease, demographics, and socioeconomic indicators such as insurance status may
identify public health opportunities to improve outcomes and minimize the health and
cost burden associated with HMB.
Menstrual disorders are a substantial reason for obstetric-gynecological
consultations (Byams et al., 2012). A common estimation of prevalence is in the range of
approximately 30% of women of reproductive age experiencing menorrhagia (Vilos et
al., 2001). Menorrhagia or heavy menstrual bleeding (HMB) thus represents the most
common gynecological presentation in women of reproductive age (Davis, 2017). This
bleeding can have a negative impact on a woman’s quality of life. If left unattended,
increased health-related costs and decreased quality of life are two expected
consequences of HMB.
Definition of Heavy Menstrual Bleeding
Heavy menstrual bleeding has a historical definition of a daily blood loss of
greater than 80 mL per cycle (Hallberg et al., 1966). In practice, the Federation of
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Gynecology and Obstetrics (FIGO) classification scheme is now considered more
practical and less confusing criteria for defining HMB (Munro et al., 2011). This scheme
recognizes other factors including; disturbances in frequency, irregular bleeding, duration
beyond eight days, heavy blood loss, and inter-menstrual bleeding episodes. The most
challenging aspect of these definitions is the practical difficulties in the quantification of
blood loss.
Normal menses should occur every 21–45 days. The bleeding duration is expected
to last at least seven days. Pad or tampon use should average 3–6/day (Haamid et al.,
2017). HMB is defined as bleeding intervals of more than 7 days with an estimated blood
loss exceeding 80 ml per menstrual cycle. Additional symptoms suggestive of HMB may
include frequent changing a pad or tampon including time intervals of less than one to
two hours. Preventative strategies such as the use of double hygiene protection to reduce
the frequency of soiling of clothes or bed sheets have been reported (Nooh et al., 2016).
When visualized, blood clots greater than one inch in diameter and effects of quality of
life have noted (Moon et al., 2017). These observations have helped clinicians frame
diagnostic conversations to be focused on measurable and quantifiable elements of HMB.
Most clinical presentations of HMB are based on self-reported perceptions.
Patient-reported concerns may be subjective and prone to bias. A retrospective analysis
of a large U.S. medical claims database identified 34,941 women diagnosed with HMB
(Copher et al., 2013). These women were insured and had pharmacy benefits indicating
access to health care. Almost three-quarters of the women who had an underlying
disorder were over 40 years of age versus 55% of the women who were classified as
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idiopathic. When the study cohort was classified by age, a trend of increasing proportion
by age was noted. The youngest age cohort aged 18 to 34 years represented 16% of the
study population. The next older cohort 35-39 years represented 21% of the population
while the oldest cohort age 40 to 49 years was 63%. The trend supports the theory that
with or without underlying causes HMB burden to healthcare systems appears to increase
over with age. Women appear to become more self-aware of their health status as they
age and with access to the care they may seek medical attention more readily. Beyond
this study are the consequences and burden of disease in women without healthcare
access.
Causes
Several causes should be suspected when HMB presentation occurs. Causes are
multifactorial. Heavy menstrual bleeding may result from several sources. Gynecologic,
systemic, or iatrogenic causes should be suspected (Brenner, 1996). Half of the cases are
attributed to defects of the coagulation system (Dilley, et al., 2001). The remaining half
does not have an identifiable cause. Among coagulation defects, platelet disorders
(Rocheleau, et al., 2017), Bernard Soulier syndrome, and underlying bleeding disorders
such as von Willebrand disease (VWD) and low levels of FVIII, FIX, FX are common
causes (James, et al., 2011). For coagulation defects, several bleeding history events
should suggest suspicion, see Table 1.
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Table 1
Sentinel Events for a Coagulopathy
Bleeding history events that should arouse suspicion of a coagulation defect
Prolonged bleeding from trivial wounds lasting >15 min
Heavy, prolonged, or recurrent bleeding after surgery
Heavy, prolonged, or recurrent bleeding after dental procedures such as a tooth
extraction
Bruising with minimal or no trauma, especially resulting in a lump 1–2 times/month
Nose bleeds lasting >10 min or requiring medical attention 1–2 times/month
Unexplained gastrointestinal tract bleeding
Anemia requiring corrective iron therapy or transfusions
Heavy menstrual bleeding
Family history of bleeding disorders such as von Willebrand disease or hemophilia
Family history of hysterectomy at a young age
Postpartum hemorrhage
Adapted from Haamid, Sass, and Dietrich, 2017

Table 2
Differential Diagnosis for Heavy Menstrual Bleeding
Differential diagnosis of heavy menstrual bleeding
Endocrine
Anovulatory bleeding
Polycystic ovary syndrome
Thyroid disease
Bleeding disorders
von Willebrand disease
Platelet dysfunction
Thrombocytopenia
Clotting factor deficiency
Infection
Sexually transmitted infections
Cervicitis
Endometritis
Pregnancy
Abortion
Ectopic pregnancy
First trimester bleeding
Gestational trophoblastic disease
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Postpartum bleeding
Medication
Anticoagulants
Depot medroxyprogesterone
Intrauterine Device
Uterine
Leiomyoma
Polyp
Aenomyosis
Malignancy
Other
Trauma
Foreign body
Hemorrhagic ovarian cysts
Adapted from Moon, Perez-Milicua, & Dietrich, 2017

Classification
HMB is classified by the International Federation of Gynecology and Obstetrics
as either structural of non-structural (Munro et al., 2011). This system uses the acronym
PALM-COEIN, see table 3. HMB is classified as either structural or non-structural.
Many cases of HMB present as secondary to other conditions. Approximately 50% of
cases are idiopathic where no known cause is identified (Byams et al., 2012).
Circumstances, where cause cannot be established, can be expected to lead to treatments
focused on symptoms versus cause.
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Table 3
Classification System for Causes of Abnormal Uterine Bleeding in Nongravid Women of
Reproductive Age
PALM:
Structural causes

Polyp abnormal uterine bleeding (AUB)
Adenomyosis AUB
Leiomyoma AUB-L

COEIN:
Nonstructural causes

Submucosal
Other

Malignancy and hyperplasia AUB
Coagulopathy AUB

Ovulatory dysfunction AUB
Endometrial AUB
Iatrogenic AUB
Not yet classified AUB
Adapted from Moon, et al., 2017
Prevalence Estimates
Estimates of prevalence vary. When HMB blood loss is objectively measured
prevalence rates range between 9 and 14% (Chodankar et al., 2018). When subjective
assessments are studied the prevalence rates reported are between 20 and 52% (Clark,
2016). Discordant prevalence estimates between objective and subjective patient-reported
approximations suggests a gap in perception of health exists. Several factors may
contribute. Life stage characteristics such as parity are not frequently studied. In the UK,
5% of women aged between 30 and 49 years consult their primary care physician each
year with HMB (Davis, & Kadir, 2017). The annual UK cost associated with the 1.5
million primary consultations for menstrual complaints exceeds £65 million (Chodankar
et al., 2018). Thus HMB frequency estimates in the 20 to 30% range appear to be
supported by care-seeking frequency and health care cost burden data.
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Community sampling may best accomplish assessing population prevalence. A
European wide internet-based survey conducted in five European countries among
women (aged 18–57 years) surveyed 4506 women. Two or more HMB symptoms were
reported in 1225 (27%) of the women. Within the cohort, 661 (27%) of the women
sought medical attention at least once a year. Iron deficiency-associated symptoms were
frequent, previous confirmed diagnosis or treatment for iron deficiency anemia occurred
in 63% of the womgen surveyed (Fraser, et al., 2015). There could be bias because the
present study was based only on women’s perceptions. The strong association with iron
deficiency would be consistent with expected pathophysiology and be a meaningful
surrogate for disease burden estimation.
Several reports suggest a frequency within the community of between 30 to 40%.
Age appears to be important, with younger populations reporting slightly higher rates. A
prevalence rate of 40% was reported in an adolescent population of women age 12 to 18
(Rocheleau, et al., 2017). In a community-based cross-sectional descriptive survey on a
randomized sample of the Swedish general population, investigators found a prevalence
rate of 32% of women experiencing heavy menstrual bleeding (Karlsson et al., 2014).
This study included an older cohort of 1547 women, aged 40–45 years old. In addition to
HMB they also reported that in general, menstrual bleeding was associated with negative
perceptions and limited social and professional activities. These negative perceptions
affected several quality of life domains in the Short Form-36v2 SF-36. These healthrelated quality of life (HRQoL) scores were significantly more affected in women
experiencing heavy menstrual bleeding than those with normal menstrual bleeding
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patterns. The Short Form-36v2 SF-36 showed that women experiencing heavy menstrual
bleeding had significantly worse HRQoL compared with women with normal menstrual
bleeding in all domains.
Anemia
Anemia is characterized by several distinguishing features that manifest via
altered erythrocyte morphology. A classic presentation of includes reduced red blood cell
quantity, low hemoglobin levels, or transformed red blood cell morphology (Kassebuam
et al., 2014). Surveillance of anemia is challenging. Iron deficiency is the most common
micronutrient deficiency worldwide (Percy, & Mansour, 2017). Globally iron deficiency
anemia (IDA) prevalence is estimated to be approximately 29% among non-pregnant
women between ages 15 to 49 (Bernardi et al., 2016). This evidence suggests that IDA is
a common problem that may be a consequence of other health-related determinants.
Frequent blood loss due to heavy bleeding is expected to be an important health status
determinant.
There are several initiating factors associated with the development of irondeficient anemia. IDA is influenced by low socioeconomic status, low body weight, and
in females who have recently given birth (Kassebaum, et al., 2014). Inadequate dietary
iron such as a vegetarian diet and chronic blood loss are known causes of anemia (Chen,
Chao, Cheng, Hu, & Liu, 2008). Most cases of anemia develop over decades which may
facilitate slow recognition or adaptation to the associated health effects. The downstream
consequences of unattended anemia may have a substantial impact on an individual’s life.
Reduced oxygen-carrying capacity can affect multiple organ systems.
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The association between age and anemia in women is complex. In early life
before puberty 3.6% of children under age five are anemic (Friedman et al. 2012). During
adolescence, the rates increase due to growth spurts, menstrual blood loss, and dietary
issues. Pregnancy adds additional demand to iron needs. IDA develops in 37% of
pregnancies among US women (US Preventive Services Task Force, 1993). In the perimenopausal period, an estimated 13% to 20% of women suffer from anemia primarily
due to excessive blood loss. After reproductive years anemia becomes less prevalent. A
constant concern regardless of life stage is the health impact associated with anemia.
Iron deficient anemia left uncorrected may cause many symptoms related to poor
health. The reduction in red cell volume may lead to outcomes due to impaired tissue
oxygen delivery. Decreased cognitive performance has been associated with IDA. During
formative years mental and motor skills may be affected (McCann, & Ames, 2007).
Women or reproductive age may experience symptoms such as weakness, fatigue,
difficulty concentrating, or poor work productivity (Haas, 1986). The susceptibility of
several important health systems to IDA reinforces the importance of recognizing risk
factors that contribute to frank anemia especially when a presentation is in an emergency
department setting.
Anemia is a global health problem that disproportionally affects women. In the
United States, racial disparity has been observed. Analysis of the 1999 – 2002 National
Health and Nutrition Examination Survey (NHANES) found persistent differences in the
prevalence of iron deficient-anemia among African American and Mexican American
women. The prevalence rate among white women was 3.3%, Hispanic was 8.7%, and for
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black women was 24.4%. The cohort examined was all under age 50 years with a
diagnosis of anemia (Cusick, et al., 2008). Factors that may contribute include high rates
of parity low socioeconomic status, lower educational attainment, and persistent HMB
(Friedman et al. 2012). Understanding the public health burden of HMB should include
exploration of effect measure modification presence. Anemia, race, and age may be
important modifiers.
Hysterectomy
Abnormal uterine bleeding due to structural causes (PALM) may respond to
medical management. The SOGC guidelines recommend preservation of fertility
especially in early reproductive life unless otherwise specified (Lefebvre, et al. 2002).
Hysterectomy may be indicated for cases of HMB refractory to conservative surgical
management or to medical treatment. When leiomyomas are present, management of
symptomatic fibroids via hysterectomy provides a durable solution to heavy menstrual
bleeding and the symptoms associated with an enlarged uterus. This recommendation
received a 1A grade. The option of medical management for other causes of HMB results
in the possibility that hysterectomy may be an option that is over-utilized when both
structural and non-structural causes are not identified.
After cesarean delivery, hysterectomy is the most frequently performed major
surgical procedure for women of reproductive age in the United States. Roughly 600,000
hysterectomies are performed each year in the United States (Whitman et al. 2008). An
estimated 20 million US women have had a hysterectomy. By age 60 more than one-third
of all women have had a hysterectomy (Whitman et al. 2008). The most common
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indication for hysterectomy was uterine leiomyoma which includes the broad
classification of menstrual disturbances. This indication accounts for 40.7% of all U.S.
hysterectomies. In population terms, the rate of hysterectomy for uterine leiomyoma was
2.2 per 1000.
Globally similar trends are observed for hysterectomy. In Denmark, a country
with comprehensive medical access, 7,700 women annually undergo elective
hysterectomy including laparoscopic hysterectomy for benign indications (Topsoee et al.,
2016). This population frequency equates to an estimated 10% lifetime risk for all Danish
women. The procedure in Denmark is most commonly performed due to abnormal
menstrual bleeding, leiomyomas, descensus of the uterus, or abdominal pain (Nielsen et
al., 2011). These utilization trends of hysterectomy support the premise that
gynecological care in first world countries for HMB may be similar.
The type of surgical procedure utilized for menorrhagia or leiomyoma appears to
differ based on patient characteristics. The less invasive laparoscopic procedure in the US
appears to be utilized differentially. A retrospective cohort study analyzing the HCUP
Nationwide Inpatient Sample databases found significant differences in the surgical
management women received for HMB based on race, gender, and insurance status (Lee,
et al. 2014). Examination of 530,154 cases between 2003 and 2010 showed that the
likelihood of women with HMB undergoing a laparoscopic hysterectomy remained
greatest for women who were under 35 years of age, white race, with high median
income defined as above the fourth quartile nationally, and with private insurance. This
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data would imply that women with HMB who seek elective surgical management receive
treatment disparities.
Another important concern is the utilization of hysterectomy for HMB due to nonstructural causes. Defects in coagulation pathways such as deficiency of Von Willebrand
factor (VWF) would not be expected to be resolved by hysterectomy. Utilization in this
situation would expose the woman to unnecessary surgical risks with a low likelihood of
success. HMB is a leading indication for hysterectomy, the most common non-obstetric
surgical procedure in women in both the United Kingdom and the United States
(Harlowa, & Campbell, 2004). The utilization of hysterectomy for idiopathic HMB is
lower than for structural causes; however, Copher et al. (2013) reported a rate of 10%
among the 21,362 idiopathic cases examined in their study. This unexpectedly high use
of surgical management among women who would most likely experience minimal
symptom improvement suggests that the burden of HMB may also include costly and
risky surgical therapies.
Hospitalizations
HMB is associated with frequent visits to physician offices, emergency
departments leading to in many cases hospitalization. Despite medical therapy is an
effective option for many women, surgical approaches are often utilized (Winston et al.,
1999). Hospitalizations for procedures such as hysterectomy accompanying HMB are
common. Analysis of a population-based survey the National Health Interview Survey
1999 found that women with the self-reported heavy menstrual flow were at least 1.45
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times more likely to utilize health care services such as hospitals versus matched control
women (Côté et al., 2003).
Evidence of disparities exists when hospitalizations are considered. Women with
HMB have similar health status comparator women undergoing hysterectomy. However,
the lower socioeconomic status appears to be important. Income disadvantage and lower
educational attainment are associated with increased exposure to surgical management
via hysterectomy and hospitalization (Marshall et al., 2000).
Quality of Life
Excessive menstrual blood loss is estimated to affect up to one-third of women
during reproductive years (El-Hemaidi et al., 2007). Perception of reduced energy
capacity and activity levels related to work and family are theorized to drive healthseeking behavior. Women who experience HMB will often present to either a primary
care physician or an emergency department primarily due to the consequent negative
influence on their daily activities (Santer et al., 2007). HMB has been shown to adversely
affect several domains important in quality of life (QoL) assessment. A cross-sectional
postal survey of 906 women in Scotland by Santer et al. (2007), found that pain was the
most frequent complaint followed by heaviness, changes in mood, and fatigue.
Consistently reported QoL concerns to include reduced energy vitality, work
productivity, social interactions, family life, and sexual functioning (Liu et al., 2007). The
primary consequences that HMB has on a woman’s health-related quality of life (HRQL)
originates from two sources (Lukes et al., 2012). The health-seeking effort associated
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with managing menstrual bleeding and the downstream consequences of excessive blood
loss, including fatigue and iron deficiency anemia.
In adolescent women, the effect of heavy menstrual bleeding on QoL is theorized
to be pronounced. Torres, et al. (2017) interviewed 46 adolescents between ages 10 and
18 years. Using the PedsQL 4.0 instrument, they found that the emotional dimensions
were most affected. In this cohort, social absences were frequently reported. Frequent
absence (at least day per month associated with at least 75% of periods) from school due
to HMB occurred in 50% of adolescents, 80.4% missed physical education, and 65.2%
limited outdoor activities or parties due to HMB. This study design also included
interviews of the subject’s parents or guardians. They found that the perceptual impact of
HMB was discordant. Parents viewed HMB as a less serious health issue and having a
lower activity impact than the adolescents. This evidence would support the premise that
the health burden accompanying HMB is often not fully appreciated even by close family
members.
The QoL differences between women with HMB and matched controls appear to
be significant in several health-related domains. A systematic review of 98 studies
supports this premise (Liu et al., 2007). Pooling SF-36 scores, women with HMB had
lower SF-36 scores for all eight subscales compared to mage matched American women.
The physical role functioning and emotional role functioning subscales were significantly
different, see table 4. These two domains assess daily tasks and work productivity
functions. The majority of the subscale scores (six of the eight) were below the 25th
percentile of the national scores. The most significant difference versus national norms
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was found in the physical role functioning domain. This difference, 60.3 vs. 83.2, was 23
points below the 25th percentile of the national norms. In most health-related domains
women across all ages appear to function well below national norms and best function in
the bottom quarter of their age-matched peers.
Table 3
Impact of HMB on QoL: SF-36 Subscale Scores Versus the National Norms
Physical
function

Role/
physical

Pain

General
health

National
norms

25th
83.3
83.2 60.9 64.2
percentile
Mean
87.5
84.4 76.7 73.8
HMB
Meta82.1
60.3 58.5 69.9
analysis
(randomeffects)
Note. Max score = 100. Adapted from Liu et al., 2007

Vitality

Social
function

Role/
emotional

Mental
Health

46.2

72.1

70.4

63.6

59.3
43.9

83.1
66.1

81.1
62.3

73.1
62.4

The Role of Age
Menstrual bleeding occurs during reproductive years beginning around age 10-12
continuing to peri-menopausal years near age 50. This study will consider HMB across a
woman’s reproductive lifespan. The health impact during the early years can be
substantial. An adolescent population reported that 60% experienced a serious effect on
life activities (Esen et al., 2016). In adult years, including peri-menopausal years HMB
continues to affect health status and quality of life (Herman et al., 2016). Regardless of
age, a women’s perception of bleeding severity does not often correlate with the
objectively measured blood loss (Gkrozou, et al., 2015). Approximately 40–50% of
women who complain of HMB have an excess of 80 ml blood loss which would suggest
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that the majority do not. This evidence would support the approach of studying and
exploring risk factors across reproductive life. The Theory of Reasoned Action would
suggest that behavioral intention would change throughout the reproductive years.
Across all age groups, HMB relies on a seldom-used definition of blood loss.
Using a meta-ethnography approach Garside, Britten, and Stein (2008) attempted to
synthesize health related findings to understand the impact of HMB among women of
reproductive age. Estimates that up to 60% of women with normal blood loss present
with HMB, including half of those treated surgically, would suggest that understanding
the characteristics of these women is important. The converse may also be expected,
there is a proportion of women who do not seek help despite having objectively heavy
blood loss. Several factors may support the uncertainty about how valid a woman’s
subjective experiences may be. These experiences are theorized to affect health-seeking
decisions and may change during life course. These can include ambivalence in assessing
their periods as problematic (Garside Britten, & Stein, 2008). Several themes emerged
from the research. Some women may have an internalized belief that suffering is an
essential component of menstrual biology. This belief may be conflated with difficulties
in assessing one’s own experience in comparison to that of other women. Thus, changing
health-seeking behavior will rely on the validity of their perception of heavy blood loss.
Cultural influences may also be important. Women who have the perception that
menstrual blood loss, even if heavy, is a necessary cleansing process may avoid seeking
help.
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The cost burden associated with a presentation to healthcare providers is
substantial across all ages. A retrospective analysis using health insurance data of 6,315
Japanese women found that after adjustment for baseline characteristics including age,
costs associated were 2.2 times higher in patients initially presenting to a healthcare
provider and 2.9 times higher for women with repeated claims (Akiyama et al., 2017).
This was significantly greater than matched controls (both P <0.0001). This supports the
hypothesis that the health burden increases as symptoms are not addressed.
Economic Burden
The economic burden from a relatively high-frequency health challenge present in
a large segment of the population is expected to be substantial. A conservative estimate
of annual direct economic costs attributed to HMB suggests that approximately $1 billion
is lost annually (Côté et al.,2001). Indirect costs may reach $12 billion annually. These
estimates do not account for intangible costs and productivity loss due to reduced vitality
or functional capacity. Direct costs can be quantified. Women who reported HMB were
more likely to consult a physician (OR = 1.48, P ≤ 0.01), present at an emergency
department (OR = 1.79, P ≤ 0.01), and to endure a related surgical procedure (OR = 1.56,
P ≤ 0.01) (Shapley et al., 2004). The 150,000 HMB related hysterectomies performed in
2005 represented 25% of the national total and consumed USD 567 million. These
demands for direct medical services demonstrate the cost burden associated with HMB.
There are very few studies exploring the impact of HMB on work productivity.
Hurskainen et al. (2001) reported that among 226 women with HMB, 20% reported
having missed work due to HMB within the previous 6 months. Structural causes such as
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fibroids may be important. In a large prospective study, Pron et al. (2003) found that 40%
of women with fibroids (80% of whom reported heavy menstrual bleeding) reported
missing work in the previous 12 months due to fibroids. The duration of lost work time
was substantial often involving several days a month. There is a temporal association
with the timing of menstruation. Among women requiring surgical management for
HMB, 39% to 55% needed to take time off work prior to surgery (Dwyer, Hutton, &
Stirrat, 1993). Cote et al. (2001) estimated that women with HMB worked 3.6 weeks
fewer per year versus matched controls. They also estimated that this annual work loss
duration translates to $1692 annually per woman. The methodology for estimation only
took into account actual absenteeism, not reduced productivity due to fatigue and reduced
vitality. Thus potential productivity reduction attributable to HMB may have been
substantially greater than just counting lost days of work.
Consequences
The consequences of HMB, a high-frequency health challenge present in a large
segment of the population require attention. A cross-sectional survey of 225 women with
heavy menstrual bleeding provided six important themes related to the consequences of
HMB (Chen et al., 2018). From qualitative interviews the authors found (a) Symptomatic
experience was very heterogeneous, (2) Symptoms experienced varied across the
reproductive life span, (3) Multiple factors influenced HMB symptoms and their health
impact, (4) HMB symptoms could adversely affect daily activities, (5) HMB was not
perceived by health care providers as a valid health issue, and (6) Treatment for women
with HMB varied in satisfactoriness and usefulness. These findings suggest that the term
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of heavy menstrual bleeding may categorize a broad spectrum of symptoms, health
related–challenges, and population burden. Women who experience HMB will often
seek medical attention primarily due to the consequent negative impact on their daily
lives and activities.
Public Health Concern
Morbidity reduction from the identification of potentially modifiable risk factors
should be the product of purpose-driven public health research. HMB is a major problem
for a substantial proportion of women of reproductive age. The patient journey is
expected to be lengthy and potentially associated with frequent emergency room visits to
address outcomes such as pain, excessive bleeding, and anemia. There is strong evidence
that women with HMB face a health care bias. A study characterizing the patient journey
of 10,354 individuals with a bleeding disorder quantifies the potential bias (Sidonio, et
al., 2017). The study focused on individuals who were serially misrecognized. This was
defined as those who visited the same specialist type at least twice for an episodic bleed
prior to diagnosis. Of the proportion (one quarter) of patients misrecognized, 82% were
women. Those in reproductive years (age 16-54) represented 54% of the cohort. The
likelihood of being misrecognized was equally distributed among the health care
providers that these patients presented to; gynecologists (35%), emergency
room/hospitalists (33%), and primary care physicians (33%). Emergency department
consultation for HMB symptoms is expected to be the culmination of several health
determinates.
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Summary and Conclusion
The literature review has identified a substantial burden associated with HMB.
Heavy menstrual bleeding is a common health problem (Davis & Kadir, 2017). The
Theory of Reasoned Action would predict that women who are uncertain about their
bleeding patterns may or may not seek medical advice. Those who are concerned or
suspect that their bleeding pattern is heavy do not have an objective assessment option.
These women may or may not have a blood loss beyond the 80 mL definition of HMB
(Gkrozou, et al., 2015). Those seeking medical assistance in the ED are theorized to
represent a cohort who may; a) be secure in the validity of their personal experience, b)
have a cultural or supportive environment where they are encouraged to seek help, and c)
there may be fear that HMB is a manifestation of other health-related concerns such as
cancer. The demographic characteristics and comorbid risk factors across the
reproductive life span in women who seek health care in the ED are not well understood.
Women experience an uncertainty about their menstrual bleeding patterns. The
question of whether or not their bleeding is abnormal is influenced by their perceptual
model. The intention and attitude to seek help in an emergency department are expected
to be driven by multiple determinants. When women do initiate health care-seeking
behavior for HMB, patients preferred a shared decision approach (Zandstraa, Busserb,
Aartsb, & Nieboer, 2017). Additionally, when an intervention was initiated, a women’s
pre-visit preference was the strongest predictor for treatment choice. These findings
would support the hypothesis of the TRA that subjective norms and health care
experience are relevant and influential in health-seeking behavior for HMB. If health
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service personnel adhere to a strict definition of HMB blood loss, they may ignore
relevant phenotypes and bias women to avoid further consultation. Understanding who
seeks consultation across the reproductive lifespan will potentially enable improved
sensitivity to needs and reduction of lifelong burden.
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Chapter 3: Research Method
Introduction
The consequences of protracted HMB include anemia, chronic fatigue, and
decreased psychosocial wellbeing (Kassebaum et al., 2014). EDs are often the first point
of medical contact and may function as a health sanctuary for those with limited
healthcare access or for those who have ignored bleeding symptoms (Livesey et al.,
2016). ED presentation for menorrhagia may indicate that an individual has exceeded a
tolerance threshold (Sriprasert et al., 2017). Those without access to gynecological
services may at increased risk for secondary health issues. Characterizing the incidence
and risk factors for women who present at the ED with HMB symptoms is not well
known. Quantifying risk factors associated with presentation, including race, age, and
comorbidities such as diabetes, hypertension, or metabolic challenges, remains
unexplored. Additionally, understanding hospital admission rates could further help
quantify the severity of inadequate care suspected to be the result of limited access to
gynecological attention (Demers et al., 2006).
To estimate population risk parameters, analysis of large national databases was
an ideal approach. The HCUP databases, which are a federal-state-industry partnership in
health data, sponsored by the Agency for Healthcare Research and Quality, allowed for
meaningful research to address the research questions. This secondary data source of ED
admissions contains over 32 million records each year from approximately 1,000 EDs
(HCUPnet, 2018). Weighted, this data sample estimates approximately 135 million ED
encounters. The NEDS contains discharges from more than 950 hospitals and
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approximates a 20% stratified sample of U.S. hospital-based EDs. A description of the
research design, data sources, and statistical plan follows.
Research Designs and Rationale
In this retrospective quantitative cohort study, I used secondary data collected
from the Agency for Healthcare Research and Quality. The study population was derived
from ED visits and hospital admissions collected by a stratified systemic random sample
from reporting hospitals. The project sample was designed to generate a study population
systematically drawn from a list of ED presentations collected. An important advantage
of this secondary data source is that the study population could be weighted to be
representative of the entire United States across medical specialties and included
academic, community, nonfederal, general, and specialty-specific centers, including
obstetrics and gynecology (see HCUPnet, 2018).
Logistic regression was used in this research as my aim was to predict whether
ED presentation due to HMB results in hospital admission or not, that is, the presence or
absence of an event is being sought. The estimated logistic regression coefficients were
used to estimate ORs for each of the independent variables in the model. The dependent
variable in the logistic regression model was the hospital admission, yes or no
(dichotomous). Logistic regression methods are appropriate to model data where the
dependent variable is dichotomous (Sun et al., 2017). A large sample set was used to
assess several risk factors. Seven predictors (independent variables) were explored in the
analysis plan, see Table 5.
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The use of secondary data to assess risk factors has been effective in identifying
risk factors (Morrison et al., 2008). The use of logistic regression in a population with
phenotypic heterogeneity has been demonstrated (Begg et al., 2013). The research design
and use of logistic regression models allowed me to address the three research questions,
which asked about demographic, health, socioeconomic, and spatial associations. Several
of the independent variables had multiple categories, which further allowed for the
characterization of high-risk individuals within the community.
A standard epidemiologic approach for modeling risk factors of a categorical
outcome typically entails fitting a polytomous logistic regression via maximum
likelihood estimation (Sun et al., 2017). By limiting the dependent variable to admission
or no admission to hospital, heterogeneity within the population was masked. Methods
such as factor analysis were used to address this limitation. Factor analysis is appropriate
to identify variables that contribute to HMB and describe how each factor’s effect may be
interpreted (Dmitrienko & D’Agostino, 2018). Understanding risk factors associated with
anemia severity provided evidence to support the research focused on women at high risk
for poor health outcomes and QoL.
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Table 5
Independent (Predictor) Variable Description
Predictor variable
(Independent)
Age
Anemia status
Diabetes status
Hypertension
Insurance status
Income
Residence location

Date type

Categories

Continuous

6

Dichotomous
Dichotomous
Dichotomous
Categorical
Categorical
Categorical

Yes or No
Yes or No
Yes or No
5
4
7

Dependent Variable
HMB was dichotomized to either no hospital admission (treat and release) or
hospital admission (admission from the ED). Hospital admission was determined from
the NRD database. Within the NRD, a hospital admission is recorded regardless of cause,
and trauma is excluded. The outcome of hospital admission was cases related to the HMB
index event. These were categorized as hospital admission. This was dichotomous, either
yes or no. These two states relied on the clinical judgment of symptoms at ED
presentation by healthcare providers and any laboratory or diagnostic interventions
performed. I assumed that ED presentation severity is a consequence of both underlying
pathophysiologies and delayed health-seeking behavior (Figure 1). Severe anemia was
expected to be the most profound HMB outcome that leads to hospitalization (Nelson &
Ritchie, 2015). The impact of anemia on well-being and health is substantial (Friedman et
al., 2012). Admission status is directly measured in the HCUP datasets, via admission
records. Construct validity was expected to be highly certain as hospital admission from
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the ED generates a unique patient billing code. The dichotomous dependent variable,
admission status, was thus a surrogate for severe HMB versus non-severe cases.
Research Questions
The research questions were as follows:
RQ1: What is the association between demographic (age), health status (anemia),
insurance status, and ED presentation for HMB?
H01: There is no statistically significant association between demographic factors
(age), health status (anemia), insurance status, and presentation to the emergency room
for women of reproductive age in the United States.
Ha1: There is a statistically significant association between demographic factors
(age), health status (anemia), insurance status, and presentation to the emergency room
for women of reproductive age in the United States.
RQ2: What is the association between health factors (comorbidities such as
diabetes and hypertension), admission for menorrhagia, and ED presentation for HMB?
H02: There is no association between health factors (comorbidities such as
diabetes and hypertension) and presentation to the emergency room for women of
reproductive age in the 30 states participating in the Nationwide Emergency Department
Sample (NEDS) in the United States.
Ha2: There is an association between health factors (comorbidities such as
diabetes and hypertension) and presentation to the emergency room for women of
reproductive age in the 30 states participating in the NEDS in the United States.
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RQ3: What is the association between location and economic status (see Song et
al. 2010) and ED presentation for HMB?
H03: There is no association between location and economic status and
presentation to the emergency room for women of reproductive age in the United States.
Ha3: There is a association between location and economic status and presentation
to the emergency room for women of reproductive age in the United States.
Methodology
The methodology captured ED HMB presentations via the NEDS database and
hospital admission events via the NRD. The International Classification of Diseases, 10th
revision, Clinical Modification (ICD-10-CM/ PCS) diagnostic codes for metrorrhagia,
menometrorrhagia, and polymenorrhoea (N91, N92, N93) respectively were used to
create the study population. Because the individual data and source hospitals were both
de-identified, the university institutional review board’s privacy and patient protection
rules was satisfied.
Women of reproductive age with the diagnosis of HMB were included in the
study sample. Women under the age of 10 and above 65 were excluded on the basis that
excessive uterine bleeding is due to causes other than those associated with reproductive
functioning. The upper age boundary was partially determined by the age stratification of
the data set. The majority of cases were below age 50. Women have been noted to have
HMB in their fifth decade (Hasselrot et al., 2018). Additionally, a check of the 2014
HCUP data set revealed that 16% of HMB cases occurred in the 45 to 64-year age
category. The mean age was 48.4 years. Age 65 and older, as expected, had zero cases,
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supporting the upper age boundary approach. Log-linear regression models were created
to assess risk for severe morbidity with risk ratios and associated 95% confidence
intervals as measures of effect. Women aged 10 to 64 years with a diagnosis of HMB
(metrorrhagia, menometrorrhagia, and polymenorrhoea) were included in the analysis.
The first exposure (RQ1) evaluated was self-reported demographic variables: age (<19,
20-29, 30-39, 40-49, 50-59, and >60 years of age), health status (anemia), insurance
status (Medicare, Medicaid, private, uninsured, or other), income for zip code (ZIP code
income quartile), and patient residence (large central metro, large fringe metro [suburbs],
medium and small metro, micropolitan and noncore [rural], plus missing). The second
exposure (RQ2) assessed was the presence of health-related factors, including diabetes
and hypertension. The severity of presentation was dichotomized as hospital admission or
not, and if a subject received a transfusion or not. The third association (RQ3) evaluated
was the patient location. The NRD captured NEDS subjects who were subsequently
admitted to the hospital.
The primary outcome of this research project is the characterization of risk factors
associated with ED presentation for HMB. Increasing HMB severity is theorized to
represent poor health-seeking behaviors including limited access to care. The severity of
HMB will be estimated via two dimensions, hospital admission and treated and released.
Stratification of the study population by hospitalization will allow for the identification of
health determinants associated with a gradation of HMB consequences. The most severe
category is proposed to represent either the most severe acute circumstance or represent a
state of the most prolonged avoidance of health care. Given the collection methods of the
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NEDS secondary data set, separating acute versus chronic severity will not be possible. A
binary logistic regression model with hospitalization status as the dependent (outcome)
variable will be developed. A fully stepwise selection algorithm for both entry and
retention in the model will be constructed. HMB severity will be categorized via
hospitalization status (yes or no). Demographic severity descriptions will be analyzed.
Hospitalization would indicate greater a risk of morbidity. Significant risk factors will be
retained in the model. Adjusted risk ratios for HMB severity with 95% confidence
intervals (CIs) as measures of effect will be calculated. The model is designed to account
for demographic and hospital factors which will be derived from fitting the log-linear
regression model.
Within the overall study population and by severity index description of the
demographic and hospital characteristics by NEDS categories will be presented. The
hospital characteristics in NEDS include the number of beds (small, medium, or large),
geographical location, the academic status captured based on teaching activity (urban
teaching, urban nonteaching, and rural), and regional location (Northeast, Midwest,
South, or West). Additional demographic categories including insurance status
(Medicaid, private, Medicare, other, uninsured), and ZIP code income quartile will be
described. Comparisons of severity indexes will be evaluated using the Chi2 test.
Population weights can be applied to data in the NEDS dataset to create national
estimates. These weights will be applied in this research. All analyses will be performed
with SPSS (v 24).
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Data Analysis
Using ICD-10-CM/PCS codes N91, N92, and N93 for metrorrhagia,
menometrorrhagia, and polymenorrhoea respectively case records from the 2016 HCUP
NEDS and NRD databases will be extracted. Variables to be measured in this study
include; age, anemia status, diabetes status, hypertension, insurance status, income,
residence location, (table 5). Data will be extracted and loaded from the HCUP source,
pre-coded for analysis by SPSS version 24 for analysis. Data will be checked for missing
variables and for entry errors. Errors such as coding for male gender and clinical
parameters that would be incompatible with life will be performed.
Descriptive statistics will be calculated to characterize the central tendency and
dispersion in the data. Odds ratios will be calculated to ascertain the association between
HMB that only presents at the ED versus patients who are admitted to the hospital. Factor
analysis is will be performed to identify latent variables or factors. Additionally,
propensity-matching scores will be calculated to control for comorbidities.
Data Analysis for Each Objective
1. To quantify the differences between HMB patient demographics (age, health
status, insurance status) in those who are only treated in the emergency
department versus those who are admitted to hospital admission, logistic
regression will be used. The odds ratio will be estimated with the 95% confidence
interval used to determine statistical significance. Descriptive summary statistics
will be described as central tendency and dispersion between both populations.
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2. To ascertain the association between health factors (comorbidities such as
diabetes and hypertension) admission for menorrhagia, and emergency
department presentation outcome (hospitalization admission, Y/N) for heavy
menstrual bleeding logistic regression, and discriminant functions analysis was
used. These methods will be used to identify potential risk factors contributing to
the most severe health situation, admission to the hospital-based on emergency
department by presentation of HMB symptoms.
3. To ascertain the association between location (spatial), and economic status
logistic regression and discriminant functions was generated to determine
variables of importance.
Population
The study population was derived from patient records captured in the HCUP
databases, NEDS 2016, the Nationwide Emergency Department Sample, and NRD, the
Nationwide Readmissions Database. This data is collected by the Agency for Healthcare
Research and Quality. Individual anonymized records will be utilized in this project.
Women with a diagnosis of excessive menstruation (ICD-10-CM/PCS codes N92 and
N93 for metrorrhagia, menometrorrhagia, and polymenorrhoea respectively) between the
ages of 10 and 64 will be included in the study population.
Both NEDS and NRD data are obtained from hospital billing information and
include both inpatient and outpatient care. Insured and uninsured patients are captured in
addition to Medicare and Medicaid covered individuals. The contributing hospitals are
classified as non-federal community hospitals. Approximately 88% of US hospitals are
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considered non-federal. Those included hospitals are; general multi-specialty community,
obstetrics and gynecology, ear nose, and throat (ENT), orthopedic, pediatric, public, and
academic medical centers. Excluded entities are 12% of the hospital population. These
excluded hospitals are; long-term care facilities, psychiatric institutions,
alcoholism/chemical dependency hospitals, rehabilitation, hospital units of other
institutions, such as prisons, and Federal hospitals (Veteran's Administration, Department
of Defense, Indian Health Service) (HCUPnet, 2018). Additionally, Federal, long-term
care, psychiatric, and tuberculosis hospitals are excluded as HCUP data sources. The
likelihood of HMB presentation at the excluded entities is assumed to be relatively low.
The design of the NEDS database is to produce both national and regional
estimates about emergency department (ED) visits. Information collected and available
for analysis includes geographic characteristics (Metro area), hospital characteristics,
patient characteristics, and the ICD code for the visit. NEDS is constructed from the
HCUP State Emergency Department Databases (SEDD) and the State Inpatient
Databases (SID). The SEDD capture discharge information on ED visits that do not result
in an admission (i.e., treat-and-release visits and transfers to another hospital). The SID
contains information on patients initially seen in the emergency room and then admitted
to the same hospital. The NEDS data files are by calendar year.
There are 37 contributing organizations to the 2016 NEDS: AR, AZ, CA, CT, DC,
FL, GA, HI, IA, IL, IN, KS, KY, MA, MD, ME, MN, MO, MS, MT, NC, ND, NE, NJ,
NV, NY, OH, OR, RI, SC, SD, TN, TX, UT, VT, WI, and WY. These States are
geographically distributed and account for 68.7 percent of the total U.S. resident
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population and 78.2 percent of all U.S. ED visits. Unweighted, the NEDS contains data
from 33 million ED visits in 2016. Weighted, the 2016 NEDS describe 145 million ED
visits. An important feature of the NEDS database is its large sample size and its
representation of the community population. These features allow for analysis across
hospital types and the study of specific events such as HMB.
When a patient is admitted into the hospital from the ED, the Nationwide
Readmissions Database (NRD) collects this information. These subjects are anticipated to
have either a severe bleeding event in need of further attention or present with
comorbidities that are exacerbated by the initial bleeding event. This too is a database of
all-payer hospital inpatient stays capable of generating national estimates of
readmissions. Outcomes collected include national readmission rates, reasons for
returning to the hospital for care, and the hospital costs for discharges with and without
readmissions. The NRD is drawn from HCUP State Inpatient Databases (SID) containing
verified patient linkage numbers that can be used to track a person across hospitals within
a State while adhering to strict privacy guidelines. Unweighted, the NRD contains data
from approximately 17 million discharges each year. Weighted, it estimates roughly 36
million discharges in the United States.
Twenty-seven States contribute to the 2016 NRD database and subsequent patient
population: Alaska, Arkansas, California, Florida, Georgia, Hawaii, Iowa, Louisiana,
Maryland, Massachusetts, Mississippi, Missouri, Nebraska, New Mexico, Nevada, New
York, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Utah, Virginia,
Vermont, Washington, Wisconsin, and Wyoming. These States are geographically
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dispersed and account for 57.8 percent of the total U.S. resident population and 56.6
percent of all U.S. hospitalizations. This does not completely overlap with NEDS and
thus means that weighting estimates applied to estimate national event rates will be
potentially more prone to error.
Sampling and Sampling Procedures
The 2016 NEDS and NRD datasets will be utilized for this research. Sampling
will be achieved by extraction of cases based on the ICD-10-CM/PCS for HMB. This
large anonymous database is suitable to answer the research questions and test the
hypothesis that HMB in the community may not be equitably distributed within races and
socioeconomic strata. This is the largest publicly available database in the United States.
The sampling frame will include women of reproductive age with the diagnosis of
HMB. Women below the age of 10 and above 65 will be excluded on the basis that
excessive uterine bleeding will be due to causes other than those associated with
reproductive functioning. Extracted health records will be checked for completeness of
the seven predictor variables. A quality check for obvious misclassifications of each
record will manually be performed. Scenarios of record exclusion include gender
categorized as male and any predictor variable that falls outside of expected normal
ranges.
Multiple years of data are available to strengthen the external validity of the 2016
findings if required. The sample population with be extracted based onICD-10 codes
along with the matching patient records. This research method is appropriate to identify
characteristics of at-risk populations within the community (Hilton et al., 2018). Studying
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comorbidities and their contribution to risk may further contribute to the understanding of
variations in HMB.
Power Analysis
Power calculations were performed using G*power software version 3.1 9.2. The
model selected was the z test, logistic regression, fixed model, alpha = 0.05, two-tail.
Logistic regression analysis will be used to address these public health research
questions. The logistic regression approach to collected predictor variables may allow for
the development of prognostic models for severity and likelihood of being admitted to
hospital. The probability of a dichotomous outcome may well be estimated with a logistic
regression model. Ranging effect sizes and estimated odds ratios, table 6 summarizes
sample size estimates.

Table 4

Summary of Power Estimates Based on Different Odds Ratios
Odds ratio
1.30
1.30
1.50
1.50
1.50
1.15
1.10
1.10

Effect size
0.20
0.10
0.20
0.10
0.20
0.10
0.10
0.10

Power
95%
95%
95%
95%
80%
95%
80%
95%

N
988
1727
417
713
242
3508
7553
13216

Gyamfi-Bannerman et al. (2018) explored a similar women’s health endpoint
using the HCUP database. The power calculations estimate a minimal sample size N of
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13,216 using a conservative estimate of the odds ratio of 1.10 with a minimal effect size
of 0.10. With larger odds ratios, the required N substantially decreases. A check of the
potential sample size using the HCUP fast stat data analysis tool (accessed November 25,
2018) for the year 2014 recorded 62,589 ED visits for diagnoses ICD-9-CM Codes
(ICD9), Principal Diagnosis: 626.2 Excessive Menstruation, and 626.3 Pubertal
Menorrhagia. There were 5,088 hospital admissions associated with the ED visits which
translates to an admission rate of 8.1%. Based on the power calculations and the
conservative effect size, the 2016 data source should be sufficient to explore the research
questions.
Figure 3
Power Versus Total Sample Size Estimations for Minimal Effect Size, Odds Ratio 1.10
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Data Analysis Plan
Multiple logistic regression analysis will be the primary statistical method utilized
to address the research questions. Logistic regression will be employed to ascertain the
relative importance of predictor variables in explaining HMB presentation in the ED.
Predictor variables to be collected include: age, anemia, diabetes, hypertension, insurance
status, income, and patient location. The dependent variable, HBM will be dichotomized
to either ED or ED/Hospital admission.
Dataset Description
The Nationwide Emergency Department Sample or NEDS is a database of
emergency department visits. The target universe is all emergency department visits from
hospital-based emergency department units in the community, non-rehabilitation
hospitals in the United States (HCUP.net 2018). The sampling frame is all emergency
department visits from hospital-based emergency department units in the community,
non-rehabilitation hospitals in the participating HCUP Partner States. NEDS is stratified
by US Region, urban or rural location, teaching status, ownership, and trauma-level
hospital with a sampling unit of hospital emergency department-level individual HMB
cases.
The NRD is a national database of hospital inpatient stays derived from individual
state inpatient databases. Patient verified linkage numbers are available to track a patient
across hospital stays while adhering to strict privacy guidelines (HCUP 2018). The NRD
is designed to enable analyses of national readmission rates. The NRD will permit
estimation of national rates of readmission for patient insurance types including the
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uninsured. Exploration of reasons for returning to the hospital for care and the hospital
costs for discharges with and without readmissions are possible.
The NEDS database approximates a 20% sample of hospital-based emergency
departments in the U.S. The NEDS sample contains over 950 hospital-based emergency
departments. From each selected emergency department, all visits are included. An
estimated minimum of 25 million unweighted observations each data year are captured.
The NEDS is designed to be nationally representative of emergency-department care
since the sampling frame is not designed with the state as a stratification variable. This
would support the premise that NEDS will provide population estimates of HMB burden
and allow for risk estimation.
Secondary Data From Patient-Reported Events
Using case definition in secondary data for HMB based on The International
Statistical Classification of Diseases and Health-Related Problems, ICD-9-CM and ICD10-CM/PCS codes will rely primarily on patient reported classification of an HMB event.
Subjective and self-reporting of blood loss may be considered to be a poor indicator of
actual menstrual loss. Reports of the quantity of blood loss women experience each
month is difficult to categorize, and precise reporting of blood loss is also problematic
(Moon et al., 2017). However, the evidence does indicate a positive correlation with
objectively measured blood loss (Quinn, & Higham, 2016). A caveat is that the positive
predictive value is low. The validity and strength of patient or self-reported events are
gaining interest and credibility (O’Mahony et al., 2016). While individual perceptions
may be prone to high degrees of variability, patient-reported outcomes (PRO) data are
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useful when large sample sets are available to represent community health (Begg et al.,
2013). PRO data may contribute to a more complete and deeper understanding of the true
population burden and provide insights into the impact of living with a disease
(O’Mahony et al., 2016). These studies support the use of self-selected secondary data
events as a basis for research. From a social change perspective, utilizing the patientreported event as being meaningful as well as being a useful indicator of true HMB will
allow for risk characterization.
Characterizing risk factors that contribute to HMB will require consideration of
both modifiable and non-modifiable factors that are theorized to contribute. Risk
variation depends on the population from which the study sample was obtained (Begg, et
al., 2013). The cases reported in the database represent individual events. These cases are
defined as individuals who have experienced and sought treatment at an ED thus
representing the sentinel event. These cases will be included in the analysis. An important
consideration is that as in self-controlled case series studies, all time-invariant
confounders that act multiplicatively on the baseline incidence are automatically
controlled (Whitaker, et al., 2018).
Research Methods
The research method considered is quantitative and retrospective in design.
Secondary data analysis will be performed. Interrogation of the Healthcare Cost and
Utilization Project — HCUP a Federal-state-industry partnership in health data sponsored
by the Agency for Healthcare Research and Quality will be performed. The Nationwide
Emergency Department Sample (NEDS) tracks information about emergency department
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(ED) visits across the country. Information includes geographic characteristics, hospital
characteristics, patient characteristics, and the nature of visits (e.g., common reasons for
ED visits, acute and chronic conditions, and injuries). The NEDS was constructed using
the HCUP State Emergency Department Databases (SEDD) and the State Inpatient
Databases (SID). The SEDD capture discharge information on ED visits that do not result
in an admission (i.e., treat-and-release visits and transfers to another hospital). The SID
contains information on patients initially seen in the emergency room and then admitted
to the same hospital. The NEDS consists of nearly 30 million records, representing over
130 million ED visits. One of the unique features of the NEDS is its large sample size,
which allows for analysis across hospital types and the study of relatively uncommon
disorders and procedures. The NEDS database will be appropriate to address research
questions one, two, and three.
To ascertain the severity of HMB events, admission to the hospital from the ED is
proposed to be an appropriate surrogate. The NEDS data indicates admission from the
ED. The HCUP nationwide readmissions database (NRD) is derived from the State
Inpatient Databases (SID). The NRD is designed to allow research related analyses of
readmissions by the same individual. This data is expected to provide evidence for
answering research question three. An important limitation of using NRD is that this
database cannot be combined across data years to create multi-year analyses. The patient
linkage numbers do not track the same person across the years. Also, the hospital
identifiers do not track the same hospital across the years. For analysis purposes, each
year of the NRD must be considered as a separate sample.
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Analytical Approach
Binary (or binomial) logistic regression will be used to address the three primary
research questions. Logistic regression is an appropriate method to predict the categorical
dependent variable (hospital admission) based on the seven continuous and/or categorical
independent or predictor variables. All analyses will be performed using IBM SPSS v25.
Data will be provided from the Agency for Health Quality Research via zip files. The
data is available in SPSS file format and requires submission of a statement of research as
well as completion of health privacy training.
The proposed research will analyze the 2016 (most recent complete dataset)
Nationwide Emergency Department Sample (NEDS) for emergency department visits
using the ICD-10-CM/PCS diagnostic codes for the most likely diagnostic codes for
heavy menstrual bleeding (Elixhauser et al., 2017). The case definition will be based on
The International Statistical Classification of Diseases and Health-Related Problems.
The ICD-10-CM/PCS uses the terms metrorrhagia, menometrorrhagia, and
polymenorrhoea (N91, N92, & N93 respectively) for HMB symptoms (Bahamondes, &
Ali, 2015).
Data Modeling
Binary (or binomial) logistic regression is a form of regression that is used when
the dependent is a dichotomy and the independents are of any type. Multinomial logistic
regression exists to handle the case of dependents with more classes than two, though it is
sometimes used for binary dependents. Logistic regression can be used to predict a
categorical dependent variable based on continuous and/or categorical independents; to
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determine the effect size of the independent variables on the dependent; to rank the
relative importance of independents; to assess interaction effects; and to understand the
impact of covariate control variables (Wang et al., 2018). The impact of predictor
variables is usually explained in terms of odds ratios. Logistic regression applies
maximum likelihood estimation after transforming the dependent into a logit variable. A
logit is the natural log of the odds of the dependent equaling a certain value or not
(usually 1 in binary logistic models, the highest value in multinomial models). In this
way, logistic regression estimates the odds of a certain event (value) occurring, a central
aim to estimate associated risk factors with HMB.
Epidemiologic methods, such as logistic regression, typically analyze data at the
individual -level. The variation observed in these approaches may be due to several
sources. Individual characteristics (compositional effects), group characteristics
(contextual effects), or the effects of omitted group-level variables on individual-level
outcomes should be anticipated (Bardenheier, et al., 2005). Logistic regression permits
the simultaneous examination of how individual-level and group-level variables relate to
individual-level outcomes, thus allowing for contextual effects that likely impact the
quality of health care. However, it does not allow the examination of both between- and
within-group variability, and how group-level and individual-level variability relate
(Begg, & Zabor, 2012). Traditional logistic regression (which, in multilevel analysis
terms, is one-level) requires the assumptions: (a) independence of observations
conditional on the independent variables and 2) uncorrelated residual errors. These
assumptions are not always met when analyzing nested data (e.g., residents clustered in
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single hospitals). The multilevel analysis will be considered when variability between
groups on individual-level outcomes exists is being considered. Since the precise
estimation of blood loss is unlikely, HMB as a category is expected to be a very
heterogeneous event. Etiologic heterogeneity will make risk estimation potentially more
challenging. Having access to a diverse and large sample set may improve the signal to
noise ratio and reduce the risk of false discovery.
Factor Analysis
Additional analysis is planned involving factor analysis. Factor analysis is
appropriate for examining a dataset with the outcome of identifying latent variables or
factors (Pan et al., 2015). Complex causes of events such as heavy menstrual bleeding
necessitate examining multiple variables to accurately describe the observed data
(Sankoh et al., 2014). An analytic strategy to explore and identify latent variables or
factors will be useful. Methods such as factor analysis are appropriate to identify
variables that contribute to HMB and describe how each factor’s effect may be
interpreted (Dmitrienko, & D’Agostino, 2018). If disproportional influences of a specific
factor(s) are identified, they may establish potential targets for public health and social
change programs. Both exploratory and confirmatory approaches will be considered.
Propensity Scores
Using secondary data limits the feasibility of examining causality. The objective
of this research project is non-causal aiming to compare a dichotomous outcome among
an HMB population with different characteristics including health status and location.
Irrespective of whether the purpose of the research is causal or not, making comparisons
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between groups can be biased when the groups are not balanced. An important concern
occurs when there are substantially different distributions of relevant covariates (Li et al.,
2018). The use of propensity scores may be a more effective method than weighting
strategies to ensure covariate balance. Propensity scores will be determined for research
question two; what is the association between health factors (comorbidities such as
diabetes and hypertension) admission for menorrhagia, and emergency department
presentation for heavy menstrual bleeding?
Parametric adjustment by regression is often influenced by model
misspecification when groups differ greatly in observed characteristics (Robins et al.,
2000). A frequently used nonparametric balancing strategy is weighting. Weights may be
applied to a sample of units in each treatment group to match the covariate distribution of
a target population (Li, & Green, 2013). Weighting approaches can then allow a
comparison between the weighted outcomes. The propensity score (PS) will be an
important statistical approach for controlling confounding in this observational data set.
Individuals who are admitted to the hospital from the ED are theorized to
represent a population who’s HMB represents a high health risk. Important comorbidities
or serious consequences due to delayed health-seeking behavior such as profound anemia
are expected to be an important reason for admission. This admission or subsequent
intervention (transfusion and/or hospital admission) would suggest a concern for
immediate well-being. Exploring the influence of factors that contribute to hospital
admission will further provide guidance to public health strategies. In an observational
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study, the factor groups are most likely are not directly comparable. Statistical adjustment
for confounders must be considered to minimize bias in outcome estimates.
Rubin (2011) demonstrated that potential outcomes may be formulated to estimate
causal effects. This method of determining an average treatment effect (ATE) involved
pre-exposure and a binary outcome (Y) – hospitalized or not hospitalized. The binary
exposure (factor) denoted as A and the pre-exposure vector of potential confounders W
are modeled. Each individual has two potential outcomes: the outcome observed had they
had the factor or exposure (A = 1), denoted Y(1), and the outcome had they not been
unexposed, Y(0) (Luque‐Fernandez et al., 2018). Only one outcome is possible for each
individual who presents at the ED. By definition Y(1) is observed for women in the factor
(exposure) group and Y(0) only for those not having the factor (unexposed) group. Two
estimates are of interest; the average treatment effect (ATE) which in this research will
represent an estimate of the influence of important factors. The ATE is defined as E[Y(1)
− Y(0)] and the marginal odds ratio (MOR) is defined as E[Y(1)] × {1 − E[Y(0)]}/{E(1 −
E[Y(1)]) × E[Y(0)]} (Luque‐Fernandez et al., 2018). Several statistical concerns exist.
A key assumption may be violated trying to estimate ATE. Identification of ATE
by logistic regression models where the factor is included as a covariate in the analysis
assumes that the effect measure of the factor of interest is constant across the levels of
confounders included in the model (Luque‐Fernandez et al., 2018). In the secondary
observational data set several assumptions cannot be validated. Greenland and Robins
(1986) introduced the G-formula to address the violation of the assumption’s constant
effect. They showed that under the untestable causal assumption required for ATE

72
estimation an alternative model may be used. They demonstrated that when conditional
exchangeability, positivity, consistency, and noninterference assumptions cannot be met,
a reliable estimate of the ATE can be obtained by using the generalization of
standardization or G‐formula. This approach considers the confounder distribution:
ATE = ΣW [ Σy P(Y= y│A = 1, W = w) - Σy P(Y – y│A = 0, W = w) ] P(W = w)
An attractive attribute of using the G‐computation is that it is based on the
estimation of the components in the G‐formula. This allows for a factor effect to exhibit
variation across levels of the confounders. A requirement is parametric modeling
assumptions and bootstrapping for the estimation of the standard error (Rubin, 2011). An
important limitation is that the G‐computation is sensitive to model misspecification. The
estimation of confidence intervals (CIs) is also complex. These limitations make Gformula utilization limited.
An alternative approach is to consider the propensity score to estimate the factor
contributing to the outcome (Luque‐Fernandez, Schomaker, Rachet, & Schnitzer, 2018).
Propensity score methods, introduced by Rosenbaum and Rubin (1983), estimate the
treatment mechanism. In our setting, where treatment is assigned at a single time point,
the propensity score is defined as the probability of being treated given the observed
confounders W, denoted P(A = 1|W). The propensity score is used to statistically balance
exposure groups in their pre-exposure covariates to estimate the ATE. This may be done
via matching, weighting, or stratification. When weighting by the inverse of the
propensity score, extreme values of the propensity score can lead to large weights,
resulting in unstable ATE estimates with high variance (in particular, ATE estimates can

73
fall outside the constraints of the statistical model). Furthermore, when analyzing
observational data with a large number of variables and potentially complex associations
among them, model misspecification is of particular concern in this case as well. Hence,
correct model specification is crucial to obtain unbiased estimates of the true ATE.
(Bühlmannet al., 2016).
Threats to Validity
An important threat to validity is to use data for research purposes for which they
are not specifically generated (Kuriyama et al., 2017). Secondary data collected from
external sources will be dependent on the rigor of the collection methods. A central
element of the validity of these research findings will be the accuracy of the disease
status. Electronic records in HCUP which rely on a categorical code such as the ICD-10CM/PCS or ICD-9CM have been found to be reliable. Studies that have compared
diagnoses and procedures reported in administrative data compared with medical records
have found acceptable levels of agreement (Casey, Schwartz, Stewart, & Adler, 2016).
Hsu et al. (2014) found that the positive predictive value (PPV) for the ICD-9 code 471.x
for nasal polyps was 85%. This would support the premise that those with the diagnostic
code do indeed have the disease.
Internal Validity
Generation of reliable risk estimates via the HCUP secondary data will require
addressing bias, confounding, and random error as alternative explanations (Casey et al.,
2016). While large sizes reduce the bias due to random error, bias due to measurement
error is independent of sample size (Mooney et al., 2015). Estimation of measures of
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association will be the outcome of the proposed research. To ensure minimal threats to
internal validity several sources was assessed. Uses of hospital records have limitations.
Sources of bias to eliminate or minimize from these records can include the
following:
1. Selection bias: Self-selection is a concern as the recorded cases will reflect
women who are theorized by the Theory of Reasoned Action (TRA) to be
motivated to seek attention driven by a perception of a health crisis. A key
premise of this theory is that HMB symptoms and combined health-related
effects are substantial enough to seek urgent care at the ED. This cohort would
represent the target population who by definition are exhibiting active
symptoms, health consequences, and are at risk for a further decline in health
status.
2. Data collection and misclassification bias: consistency in measurement. Will
the outcomes be measured or recorded differently by different health care
providers. Based on the ICD classification system and the broad definition of
HMB, using diagnostic codes ICD-10-CM/PCS terms for metrorrhagia,
menometrorrhagia, and polymenorrhoea (N91, N92, N93), and ICD-9-CM
codes for metrorhagia (626.6), uterine leiomyoma (218), excessive or frequent
menstruation (626.2) and premenopausal menorrhagia (627.0) should be
sufficient to generate a study population with a consistent definition of HMB.
3. Attrition bias: Subjects will remain to contribute as long as they continue in
the health care system and seek care (Casey et al., 2016). As each ED

75
presentation is an incident event of interest, continuous enrollment in a health
care system should minimize this bias. However, if access to the system is
interrupted, then underestimation of the magnitude of the population health
problem may occur. The motivation to seek care in the ED is theorized to be
driven by high degrees of severity which is expected to reduce attrition effects
in individuals with access and also strengthen the likelihood of accurate
disease coding.
4.

Nonparticipation bias: Another element of a systematic error related to
participation in the health care system. Nonparticipation is expected to result
in underestimation of the overall population problem, and potentially skew the
study population towards individuals with higher income, educational
attainment, and access to health care resources. Individuals who choose not to
seek care are theorized to have symptoms that may be deemed non-severe or
having minimal impact on the quality of life.

5. Recall bias: Likely to be minimal by using patient record data collected at the
time of ED presentation.
6. Statistical regression: possible but reduced by large sample size.
I did not explore an association between exposure and HMB. Confounding by
extraneous effects such as age and other factors will be stratified and adjusted for.
Confounding by indication and severity must be discussed. The presence of symptoms
(indication) is the selection criteria for inclusion. The severity of symptoms will represent
a stratum that the ICD codes will not be able to categorize. This study will use the criteria
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of hospital admission as a surrogate for either severe symptoms requiring additional
complex management or a compromised health state that requires additional support. In
either case, hospital admission from the ED will be classified as a severe health state.
Random error due to inaccurate HMB classification will be assessed by screening
the study population data for errors such as a male being coded for HMB. Elimination of
records containing men presenting with HMB will be done. Also, women below and
above the reproductive age bands of 10 years on the bottom and 65 years on the top will
be considered unlikely to have HMB. The HCUP allows for the identification of women
who are readmitted for the same indication in the NRD. To account for multiple
readmissions, within 30 days, only the first readmission will be included.
Interpretation of the analysis should keep in mind several limitations. First, the
data is sourced from administrative records and does not provide information on elements
that may influence outcomes such as resources within a hospital, staffing, protocols, and
the infrastructure. These inputs may contribute to the interventions utilized and admission
decisions. Detailed data on individual patient management are also not available. This
research cannot determine the overall health burden associated with HMB presentation.
The second limitation is that the exposure event was identified through hospital
record coding. Any misdiagnosis or comorbid conditions being coded as the initial
diagnosis could lead to an underestimation of HMB events. Third, estimating the actual
disease burden from HMB is a challenge using this data. Factors involved in the
classification of the most severe situation; hospital admission and the decision to treat or
counter anemia (transfusion) may be driven by factors not available in the health record.
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External Validity
The generalizability of the findings will be established once the study population
is described and characterized. The primary concern will be how representative the
sample is. Subjects who seek attention in the ED are theorized to have severe symptoms
prompting health-seeking action. This population may not be representative of
individuals who have access to gynecological care and would thus be managed in a
physician’s office. The HCUP databases do not capture such visits. These HMB visits
collected in NEDS and NRD will be limited to those seeking attention in an ED. The
study sample will thus represent the more serious or troublesome conditions and not the
mild conditions.
Ethical Procedures
An important ethical procedure is an assurance that the risk of unintentional
disclosure of personally-identifying information is eliminated (Mooney, & Pejaver,
2018). The HCUP databases are consistent with the definition of limited data sets under
the HIPAA Privacy Rule and contain no direct patient identifiers. Data released to AHRQ
for the HCUP Databases are subject to the data standards and protections established by
the Health Insurance Portability and Accountability Act of 1996 (HIPAA) (P.L. 104-191)
and implementing regulations (“the Privacy Rule”). Consequently, HCUP Databases may
only be released in “limited data set” form, as that term is defined by the Privacy Rule, 45
C.F.R. § 164.514(e). HCUP data may only be used by the data recipient for research
which may include analysis and aggregate statistical reporting. AHRQ classifies HCUP
data as protected health information under the HIPAA Privacy Rule, 45 C.F.R. §
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160.103. The Walden University IRB approval number for this research is 08-06-190414061.
Summary
The 2016 NEDS dataset was used for this research. This large anonymous
database is suitable to answer the research questions and test the hypothesis that HMB in
the community may not be equitably distributed within geographic location and
socioeconomic strata. This is the largest publically available database in the United
States. Multiple years of data are available to strengthen the external validity of the 2016
findings. Logistic regression was used to predict a categorical dependent variable based
on continuous and/or categorical independents; to determine the effect size of the
independent variables on the dependent; to rank the relative importance of independents;
to assess interaction effects, and; to understand the impact of covariate control variables.
Characterizing the incidence and risk factors for women who present at the ED
with HMB symptoms is not well known. Quantifying risk factors associated with
presentation including age, comorbidities such as diabetes, hypertension or, metabolic
challenges remains unexplored. Studying comorbidities and their contribution to risk may
further contribute to the understanding of risk and variations in HMB.
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Chapter 4: Results
Introduction
The consequences of protracted HMB include anemia, chronic fatigue, and
decreased psychosocial wellbeing (Kassebaum et al., 2014). EDs are often the first point
of medical contact and may function as a health sanctuary for those with limited
healthcare access or for those who have ignored bleeding symptoms (Livesey et al.,
2016). ED presentation for menorrhagia may indicate that an individual has exceeded a
tolerance threshold (Sriprasert et al., 2017). Those without access to gynecological
services may be at increased risk for secondary health issues. Characterizing the
incidence and comorbidities for women who present at the ED with HMB symptoms is
not well known. Quantifying risk factors associated with presentation, including age,
comorbidities such as diabetes, hypertension, or health challenges, remain unexplored.
Additionally, understanding hospital admission rates could further help quantify the
severity of inadequate care suspected to be the result of limited access to gynecological
attention (Demers et al., 2006).
Methodology
The methodology captured ED HMB presentations via the NEDS database and
hospital admission events via the NRD. The ICD-10-CM/ PCS diagnostic codes for
metrorrhagia, menometrorrhagia, and polymenorrhoea (N92 & N93) respectively were
used to create the study population. Because the individual data and source hospitals are
both de-identified, the university institutional review board’s privacy and patient
protection rules were satisfied.
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Women of reproductive age with the diagnosis of HMB were included in the
study sample. Women under the age of 10 and above 60 were excluded on the basis that
excessive uterine bleeding would be due to causes other than those associated with
reproductive functioning. Log-linear regression models was created to assess risk for
severe morbidity with risk ratios and associated 95% CIs as measures of effect. Women
aged 10 to 60 years with a diagnosis of HMB (metrorrhagia, menometrorrhagia, and
polymenorrhoea) were included in the analysis. The first exposure (RQ1) evaluated selfreported demographic variables and age (<19, 20-29, 30-39, 40-49, 50-60 years of age);
ethnicity was not analyzed as many states do not identify race in their reporting data sets.
Additionally, health status (anemia), insurance status (Medicare, Medicaid, private,
uninsured, or other), income for zip code (ZIP code income quartile), and patient
residence (large central metro, large fringe metro [suburbs], medium and small metro,
micropolitan and noncore [rural]) data was analyzed. The second exposure (RQ2)
assessed the presence of health-related factors, including diabetes, depression, headache,
nausea, low back backache, and hypertension. The severity of presentation was
dichotomized as admission to a hospital or not, and if a subject received a transfusion or
not. The third association (RQ3) evaluated was the location. I assumed that access to
specialized care and comprehensive resources was more likely available in larger
metropolitan locations versus micropolitan and rural communities. The NRD captured
NEDS subjects who were subsequently admitted to hospital.
The primary outcome of this research project is the characterization of risk factors
associated with ED presentation for HMB. Increasing HMB severity is theorized to be
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associated with poor health-seeking behaviors, including living conditions of limited
access to primary care via location or insurance status. The severity of HMB was
estimated via two dimensions, hospital admission and those diagnosed with HMB.
Subjects hospitalized were deemed to have the greatest health burden. Those women with
HMB who are hospitalized are proposed to either represent the most severe acute
circumstance or represent a state of the most prolonged avoidance of health care. Given
the collection methods of the NEDS secondary data set, assessing the associated quality
of life was not possible. I developed a binary logistic regression model with
hospitalization (yes or no) as the dependent (outcome) variable. A fully stepwise
selection algorithm for both entry and retention in the model was constructed. HMB
severity was categorized via hospitalization status. I also describe demographic
descriptions. Significant risk factors were retained in the model. I calculated adjusted risk
ratios for HMB severity with 95% CIs as measures of effect. The model was designed to
account for demographic and hospital factors, which were derived from fitting the loglinear regression model.
In addition, I describe demographic categories including insurance status
(Medicaid, private, Medicare, other, uninsured) and ZIP code income quartile.
Comparisons of severity indexes were evaluated using the Chi2 test. Population weights
can be applied to data in the NEDS dataset to create national estimates. These weights
were applied in this research. All analyses were performed with SPSS (v 25).
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Results
The HMB presentation was captured from the ED presentations via the NEDS
database. The 37 contributing states are distributed evenly by geographical regions. They
accounted for 68.7% of the total U.S. resident population and 78.2% of all U.S. ED visits.
The International Classification of Diseases, tenth revision, Clinical Modification (ICD10-CM/ PCS diagnostic codes for metrorrhagia, menometrorrhagia, and polymenorrhoea
(N92, N93) respectively were used to create the study population, see Table 7. These
codes captured both HMB and abnormal uterine bleeding. Both terms are frequently used
for bleeding that is characterized as either heavy and/or irregular (Rosen et al., 2020).

Table 5
Heavy Menstrual Bleeding ICD-10-CM Codes Used for Cohort Extraction
ICD-10-CM code
N92.0
N92.1
N92.2
N92.3
N92.4
N92.5
N92.6
N93.0
N93.8
N93.9

Description
Excessive frequent menstruation with the regular cycle
Excessive and frequent menstruation with an irregular cycle
Excessive menstruation at puberty
Ovulation bleeding
Excessive bleeding in the premenopausal period
Other specific irregular menstruation
Irregular menstruation
Other abnormal uterine and vaginal bleeding
Other specified abnormal uterine and vaginal bleeding
Abnormal uterine and vaginal bleeding unspecified

To create the study cohort, I used the primary core diagnosis (I10_Dx1). The
NEDS 2016 core data file contained 32,677,936 patient records. Using the SPSS
command “case select,” 111,555 cases were extracted using the ICD-10-CM
identification codes listed in Table 7. This data set filtered for age (SPSS command

83
“AGE >= 10 AND AGE <= 60”) and checked for coding errors, such as males in the data
set. Table 8 describes the summary age demographics of the 10 HMB ICD-10 codes
used. Three codes, N92.0, N93.8, and N93.9, represented 89.96% of the selected cases. I
performed analyses using the entire NEDS HMB cohort.
Table 6
Demographic Distribution of ED Presenting Women by HMB ICD-10-CM Code
ICD-10-CM
HMB Code
92.0
92.1
92.2
92.3
92.4
92.5
92.6
93.0
93.8
93.9
Total

N

11,485
5,406
63
27
597
444
4,267
346
40,771
48,102
111,555

Age
Mean
31.20
30.48
13.92
25.59
44.09
27.69
25.69
27.93
31.34
30.84

Median
30
29
12
24
47
25
24
26
29
28

Mode
22
22
12
22
50
22
22
18
22
22

The mean age of the entire HMB ED cohort was 30.89 years, the median was
29.00, and the standard deviation was 10.37 years, see Figure 4. The interquartile range
was 16 years (IQR = 21 – 37). The mode was 22 years of age (N = 6,197). The
distribution skewness was +0.517, indicating that most of the HMB cases were at the
younger end of the age spectrum. Kurtosis was -0.517, indicating that the curve is flat.
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Figure 4
Age Distribution of HMB ED Cohort, NEDS Dataset

The presentation was evenly distributed throughout the calendar year, see Table 9.
No seasonal variation was detected among the 99,446 valid cases. The expected
admission by month was 8,287 patients. The HMB cohort admission frequency ranged
from a low in December of 7,528 presentations (7.57%) to a high in August of 8,819
cases (8.89%), see Table 9. The 95% CI was 282 (95% CI: 8,005 – 8,569). During the
week, 74.6% (N = 83,268) of cases presented from Monday to Friday. The weekend
presentation was lower than expected, 25.4% (N = 28,285) of cases. An expected
weekend total assuming equal distribution by day would be 31,873 patients. The
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quarterly distribution of discharges was uniform. Quarter 1 was 24.8%, Quarter 2 was
25.1%, Quarter 3 was 26.2%, and Quarter 4 was 23.8%.
Table 7
Monthly Distribution of HMB ED Presentation
Month
January
February
March
April
May
June
July
August
September
October
November
December

N
8700
7568
8389
8343
8543
8070
8708
8819
8554
8417
7807
7528

Frequency (%)
8.75
7.61
8.44
8.39
8.59
8.11
8.76
8.89
8.60
8.85
7.85
7.57

The majority of the NEDS HMB cohort women were treated routinely, referred to
as treat and release, N =105,742 (94.8%). The 5,813 women who were not released had
outcomes recorded in table 4.4. Of note, the death rate recorded was very low (0.10%). A
majority of women, 48.49% decided for reasons unknown to leave the ED against
medical advice. A majority of the HMB women had multiple diagnoses at ED
presentation, Figure 5.
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Figure 5
Number of Diagnoses Associated With Each Patient

Table 8
Disposition of Women Not Treated and Released From the ED
ED disposition
Transfer: short term hospital
Transfer: another type of facility
Home health care
Against medical advice
Admitted as an inpatient to the hospital
Died in ED
Not admitted to this hospital, destination
unknown
Total

N
466
207
32
2,819
2,167
6
116

Frequency (%)
8.02
3.56
0.55
48.49
37.28
0.10
2.00

5,813

100.00

Patient location and income are theorized to be important determinants to health
status (Diez Roux 2001). The HMB cohort location is described in Table 11. There is an
excess of cases from large metropolitan areas (58.17%) versus smaller and rural areas
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(41.57%). Large central metropolitan areas contributed significantly (P < 0.001) more
patient cases (Chi2 Calc = 49,477).
Table 9
Geographic Distribution of HMB ED Cohort
Location
N
Large central metropolitan
41,841
Large fringe metropolitan
23,051
Medium metropolitan
22,136
Small metropolitan
10,066
Micropolitan
8911
Rural
5264
Missing
286
Total
111,555

Frequency (%)
37.51
20.66
19.84
9.02
7.99
4.72
0.26
100.00

Income is also an important determinant of health (Erwin, & Brownson, 2017).
Analysis of the median household income quartiles for the HMB patient’s ZIP code
shows a significant trend towards patients coming from the lowest income strata, Table
12. Comparing $1-42,999 with next income strata $43,000-53,999, the 13.37% difference
was significant P < 0.0001 (95% CI: 12.69% to 14.05%). The lowest two median
household income quartiles represent 65.81% of the patient cohort. This trend would be
consistent with the expectation that the emergency department serves a role in providing
medical care access to the poorest segment of society.
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Table 10
Median Household Income Quartile by Patient ZIP Code
Median household income
$1 – $42,999
$43,000 - $53,999
$54,000 - $70,999
$71,000 or more
Missing
Total

N
44,160
29,246
21,886
14,822
1,441
111,555

Frequency (%)
39.59
26.22
19.62
13.29
1.29
100.01

The cost associated with ED presentation is not inconsequential. Total charges
exhibit wide variation, Table 13. From the ED cohort total, associated charges for
86.56% of cases where charges was reported is $325,756,680. The charges were heavily
skewed to the lower cost range, skewness coefficient = 5.184. The 10th percentile cost is
$854; the 90th percentile is $6,629. The mean charge for an HMB patient was $3,373.37,
mode $2,150.00.
Table 11
Total Charges Associated With HMB ED Visit, N = 96,567
Mean
Mediana
Mode
Range
Min
(St Error)
$3,373
$2,486
$2,150
$127,217
$100
(10.86)
a: calculated from grouped data

Max
$127,317

Total
charges
$325.8 M

Research Question 1
RQ1: What is the association between demographic (age), health status (anemia),
insurance status, and ED presentation for HMB?
H01: There is no statistically significant association between demographic factors
(age), health status (anemia) insurance status, and presentation to the emergency room for
women of reproductive age in the United States.
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Ha1: There is a statistically significant association between demographic factors
(age), health status (anemia) insurance status, and presentation to the emergency room for
women of reproductive age in the United States.
Anemia cases were selected using ICD-10/CM code D64.9 with Dx_1 as the
secondary diagnosis filter. Analysis of the association between age, anemia, and
insurance status is summarized in Table 14. One-way Analysis of Variance (ANOVA)
found a significant anemia burden in the 40-49-year age group, p = 0.012 (F = 10.51),
Figure 6. The mean age of women presenting with anemia is 34.81 years, the mode was
42 and 47 years (227 cases each). Women between 40-49 years had an incidence rate of
7.41% for anemia as comorbidity, double or greater proportionately than the other age
groups.
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Table 12
Association Between Age, Anemia, and Insurance Status
Age
10 –
19
20 –
29
30 –
39
40 –
49
50 60
Total

N

Anemia
Insurance status
D64.9 Medicare Medicaid Private
Self
(%)
13,853
415
3
266
106
64
(3.00)
44,466
1,243
13
501
333
347
(2.80)
27,929
1,261
44
487
415
248
(4.52)
19,241
1,426
55
444
581
723
(7.41)
6,066
387
19
105
186
60
(6.38)
111,555
4732
134
1803
1621
1442
(4.24)
(0.12)
(1.61)
(1.45) (1.29)

Figure 6
Anemia Distribution Among HMB ED Cohort

No
Charge
1

Other

11

36

12

54

50

185

6

11

80
(0.07)

292
(0.26)

15
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Insurance status among women with anemia revealed several trends. Of the 4,732
cases Medicaid, private insurance, and self-payment represented 92.67% of the insurance
status. Each of these three payment schemes were consistently distributed across all age
groups. The chi-square test for independence rejected the null hypothesis that insurance
status was the same for all age groups of HMB women with anemia. The calculated λ2 =
3858 was well above the critical value λ2 df = 20, α = 0.05 = 10.85
Overall health in the women who seek medical care via presentation in EDs is
theorized to seek care when health concerns reach a tipping point. Anemia prevalence in
the HMB cohort was expected to be greater than the rate found in the general population.
The Theory of Reasoned Action may explain differences in the anemia prevalence
between the general US population and the HMB cohort. A recent study from the
National Health and Nutritional Examination Surveys (NHANES) data may provide
context (Le, 2016), Table 15. In the direct age group comparisons, women in the 30-39,
40-49, and 50-50 had significantly higher rates in the HMB cohort versus the NHANES
population of the same year. The overall incidence of anemia in the HMB cohort was
always greater.
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Table 13
HMB Cohort Anemia Frequency Versus NHANES Prevalence

Age
10 - 19
20 - 29
30 - 39
40 - 49
50 -60

HMB cohort
Anemia
prevalence
3.00
2.80
4.52
7.41
6.38

95% CI
2.71 - 3.30
2.64 – 2.96
4.37 - 4.88
7.03 - 7.81
5.76 – 7.05

Age
12 - 14
15 - 29
30 - 39
40 - 49
50 - 59

NHANES cohort
Anemia
prevalence
0.9
2.4
3.2
4.5
1.6

95% CI
0.4 - 1.4
1.8 - 3.0
2.5 - 3.9
3.5 - 5.5
1.0 - 2 .1

Comparisons between anemia proportions by age revealed several significant
differences, Table 16. Older age groups were generally significantly different. The
second oldest cohort (40-49 years) had a significantly greater proportion of women with
the comorbidity of anemia versus each age group except versus age 50-60. Women under
age 29, in both groups, had significantly less anemia versus the older women. The greater
proportion of anemia in older women supports the model that HMB is an increasing
health burden with age.
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Table 14
Comparison of Anemia Proportion in HMB ED Cohort by Age
Age

10-19
P-value
difference
(95% CI)

10-19
-

20-29
P-value
difference
(95% CI)
0.832
0.2%
(-1.45 to
2.46)

20-29
-

30-39
P-value
difference
(95% CI)
0.179
1.52%
(-0.83 to
3.32)
0.0221
1.72%
(0.24 to 3.23)

30-39
-

40-49
P-value
difference
(95% CI)
0.0013
4.41
(1.95 to
6.35)
<0.0001
4.61%
(2.96 to
6.28)
0.0017
2.89%
(1.09 to
4.68)

40-49
-

50-60

50-60
P-value
difference
(95% CI)
0.029
3.38%
(0.44 to 6.53)
0.0010
3.58%
(1.28 to 6.57)
0.140
1.82%
(-0.55 to
4.92)
0.487
1.03%
(-2.12 to
3.54)
-

Research Question 2
RQ2: What is the association between health factors (comorbidities such as
diabetes and hypertension), admission for menorrhagia, and ED presentation for HMB?
H02: There is no association between health factors (comorbidities such as
diabetes and hypertension) and presentation to the emergency room for women of
reproductive age in the 37 states participating in the Nationwide Emergency Department
Sample (NEDS) in the United States.
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Ha2: There is an association between health factors (comorbidities such as
diabetes and hypertension) and presentation to the emergency room for women of
reproductive age in the 37 states participating in the NEDS in the United States.
Health-related challenges might present in several forms. Heavy menstrual
bleeding is often associated with medical comorbidities and downstream health-related
problems (Borzutzky, & Jaffray, 2020). These comorbidities may include physical
problems such as low back pain, headache, and nausea. Additional wellness indicators
such as diabetes, hypertension, and depression might also reflect on the propensity of
these women to ignore other important health determinants. Examination of several
comorbidities is listed in Table 17.
Table 15
Comorbidity ICD-10-CM Codes
ICD-10-CM code
D64.9
I10
E11.9
R51
R11.0
M54.5
F32.9

Description
Anemia
Essential primary hypertension
Diabetes type II
Headache
Nausea
Low back pain
Depression applicable to generalized unhappiness

The HMB cohort was interrogated for each of the comorbidities. Table 18
summarizes the overall frequencies; Table 19 provides details for each HMB code. The
overall admission rate was 2.82%, with 3,149 women being admitted. Physical
complaints appear to be relatively minor in this population.
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Table 16
Comorbidity Frequency in HBM Cohort
Comorbidity
Anemia
Hypertension
Diabetes
Headache
Nausea
Low back pain
Depression

Number
4,732
3,194
841
654
590
500
412

Frequency
4.24%
2.86%
0.75%
0.59%
0.52%
0.45%
0.37%

Table 17
HMB Comorbidities of ED Presenting Women by HMB ICD-10-CM Code
ICD10
Code

Anemia
(%)

Hypertension
(%)

Diabetes
(%)

Depression
(%)

Headache
(%)

Nausea
(%)

N92.0

801
(6.96)
292
(5.39)
3
(4.5)
0

304
(2.64
150
(2.77)
0

41
(0.36)
47
(0.87)
0

38
(0.33)
20
(0.37)
0

61
(0.53)
29
(0.54)
0

56
(0.49)
21
(0.39)
0

0

0

0

0

0

35
(5.7)
11
(2.48)
57
(1.44)
2
(0.58)
2049
(4.99)
1482
(3.08)
4,732
(4.24)

48
(7.64)
7
(1.58)
54
(1.35)
5
(1.44)
1332
(3.24)
1294
(2.69)
3,194
(2.86)

5
(0.80)
1
(0.23)
23
(0.57)
5
(1.44)
366
(0.89)
353
(0.73)
841
(0.75)

3
(0.48)
1
(0.23)
15
(0.37)
0

4
(0.64)
1
(0.23)
33
(0.82)
0

0
3
(0.68)
59
(1.47)
0

155
(0.38)
180
(0.37)
412
(0.37)

273
(0.66)
244
(0.51)
654
(0.59)

216
(0.53)
256
(0.53)
590
(0.52)

N92.1
N92.2
N92.3
N92.4
N92.5
N92.6
N93.0
N93.8
N93.9
Total

Low
back
pain
(%)
41
(0.36)
17
(0.31)
0
1
(3.40)
1
(0.16)
2
(0.45)
23
(0.57)
2
(0.58)
177
(0.43)
236
(0.49)
500
(0.45)

Hospital
admission
(%)
735
(6.38)
345
(6.37)
2
(3.03)
1
(3.70)
71
(11.31)
6
(1.35)
13
(0.37)
15
(4.19)
893
(2.12)
1066
(2.22)
3149
(2.82)
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History of anemia would suggest chronic blood loss (Sekhar, et al., 2017).
Examining the HMB cohort for a secondary diagnosis of iron-deficient anemia,
(unspecified) ICD-10-CM D50.9 resulted in 689 women being identified. The mean age
is 32.99, years, median 32.86, mode of 42 and range was between 11 and 57 years, Figure
7. This distribution was significantly older (1.97 years) than the HMB cohort, mean age
32.86 versus 30.89 years, P < 0.001(95% CI: 1.1929 - 2.7471).
Figure 6
Secondary Iron Deficiency Among HMB ED Cohort

Women with iron deficiency were also more likely to come from the lowest
household income strata, 44.29%; between $1 - $42,999. Compared to the overall HMB
cohort (39.59), this was numerically greater but not significantly different, P = 0.128. The
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lowest income group was significantly greater in proportion than the next most frequent
group ($43,000 – 53,999), 44.29% versus 25.83%, λ2 = 13.771 p = 0.002 (95% CI:
8.9639% - 27.5334%). The proportion of these women being in poverty was high. Total
charges associated with iron deficiency were greater compared to the HMB cohort. The
mean charge in the ED was $4,364.97, the median charge $2,957.00. Total charges
ranged from a minimum of $271 to a maximum of $35,674.00. Compared to the HMB
cohort, the Mean difference of $991 was significantly greater, P <0.001 (95% CI:
712.2287 to 1269.7713).

Transfusion Cohort
Women who have lived with a heavy menstrual bleeding burden for years are
theorized to be at greater risk for more intensive interventions at the ED. Prolonged
excessive bleeding cycles may lead to iron loss, anemia, and the need for interventions
(Sekhar et al., 2017). Potential consequences include being admitted to the hospital and
being transfused in the ED. Examining the NEDS HMB cohort for transfusions using
CPT code 36430 (transfusion, blood, or blood components) identified 339 women who
received a transfusion. The mean age was 39.45 years (SD 9.934), Figure 8. Compared to
the overall HMB cohort, and other anemia comorbidities, the women who received a
blood transfusion in the ED were significantly older, Table 20
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Table 18
Blood Loss Comorbidity Comparisons
Comorbidity

HMB
Cohort

Anemia

Secondary
Iron
Deficiency
Transfusion

N

Mean
(SD)

HMB

Anemia

Secondary Transfusion
Iron Def
P-value
P-value
P-value
P-value
Difference Difference Difference Difference
(95% CI) (95% CI) (95% CI)
(95% CI)
111,555 30.89
<0.001
<0.001
<0.001
(10.37)
3.92
2.10
8.56
(3.62 to
(1.33 to
(7.45 to
4.22)
2.87)
9.67)
4,732
34.81
< 0.001 <0.001
(10.83)
1.82
4.60
(-2.68 to (3.46 to
0.96)
5.82)
698
32.99
<0.001
(11.13)
6.46
(5.08 to
7.83)
339
39.45
(9.34)
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Figure 7
Age Distribution of Women Who Received a Transfusion in the ED

Access to interventional procedures in the ED such as a transfusion should be
independent of income status. Examination of the primary payment data revealed a trend
of increasing transfusions associated with great income. Those who received a
transfusion were older and came from households with increasing median income, Figure
9. There were no significant differences in income proportion by frequency. When the
age of each income quartile was factored in, the comparison of the highest versus lowest
income quartile was significant, difference = 4.48 years (p = 0.0033 95% CI: 1.51 to
7.45).

100
Figure 8
ED Transfusion by Age and Median Household Income Quartile

A two contingency analysis was performed to evaluate whether primary payer
was different across household income quartiles. Payer and household income were
found to be significantly related, Pearson χ2 (12, N = 331) = 28.043, p = 0.005, Cramer’s
V = 0.17. Follow-up pairwise comparisons between Medicaid and private insurance was
performed to evaluate the differences among the proportions at each income quartile. The
significant comparisons are shown in Table 21 across three comparisons, Figure 10. The
Holm’s sequential Bonferroni method to control for Type 1 error across the four
comparisons was used.
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Figure 9
Medicaid Versus Private Insurance Across Household Income Quartiles

Table 19
Results From Pairwise Comparisons Medicaid Versus Private Insurance Using Holm’s
Sequential Bonferroni Method
Comparison
First quartile vs the
fourth quartile
First quartile vs the
third quartile
First quartile vs the
third quartile

Pearson chi-square
14.58

P-value (alpha)
<0.001 (0.05)

Cramer’s V
0.33

3.15

0.076 (0.25)

0.15

7.812

0.005 (0.017)

0.25

Hospital Admitted Cohort: Nationwide Readmissions Database (NRD)
HMB women admitted to hospital are theorized to represent a more serious health
state. Comparing those admitted will address research question two. Twenty-seven states
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that contributed to the 2016 Nationwide Readmissions Database (NRD): Alaska,
Arkansas, California, Florida, Georgia, Hawaii, Iowa, Louisiana, Maryland,
Massachusetts, Mississippi, Missouri, Nebraska, New Mexico, Nevada, New York,
Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Utah, Virginia,
Vermont, Washington, Wisconsin, and Wyoming. These States account for 57.8 percent
of the total the U.S. resident population and 56.6 percent of all U.S. hospitalizations. All
NRD states are included in the NEDS sample. To account for the smaller NRD
contributing state sample, NRD results will be adjusted for the difference in US resident
population, 68.7% versus 57.8%, by a factor of 1.189.
HMB admissions to the hospital was 17,894 women. The mean age of admission
was 40.77 years of age. These women were significantly older than women who present
to the emergency department, difference = 9.88 years, P < 0.001 (95% CI: -10.04 to 9.72) Figure 8. Length of stay (LOS) in hospital exhibited a wide range between 0 to 140
days. Mean LOS was 2.10 days, median 2.00 days, standard deviation of 2.20 days,
Figure 11. The number of women admitted for four days or less was 95.2%. LOS was
consistent across all age groups and by comorbidity, Table 22. Low back pain was
excluded from this analysis as only 10 cases were recorded as a secondary diagnosis
code. For low back pain, a total of 15 days of admission days were recoded with total
charges of $102,299 or $6,819 per day.
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Table 20
Mean LOS by Age and Comorbidity for Women With HMB Admitted to Hospital
Age
N

Anemia
N = 924
1.69
(0.210)
1.37
(0.109)
1.78
(0.059)
1.83
(0.069)
1.63
(0.088)
1.75
(0.041)
1596

Comorbidities
Hypertension
Diabetes
N = 1,138
N = 177
2.00*
0.5*
(NA)
(NA)
1.97
2.33*
(0.161)
(NA)
2.13
2.02
(0.085)
(0.19)
2.01
2.05
(0.050)
(0.120)
2.21
1.85
(0.123)
(0.154)
2.08
2.01
(0.041)
(0.088)
2340
354

10-19
377
(SE)
20-29
1,322
(SE)
30-39
5,167
(SE)
40-49
8,851
(SE)
50-60
2,177
(SE)
Total
(SE)
Total
LOS
Total
$29.3M
$38.9M
Chrg
*
Less than 10 cases per cell, not meaningful

$6.2M

Headache
N = 19
1.60*
(NA)
1.40*
(NA)
2.0*
(NA)
1.6*
(NA)
1.0*
(NA)
1.53
(0.208)
29

Depression
N = 204
1.0*
(NA)
1.50
(0.374)
1.89
(0.189)
1.71
(0.107)
1.79
(0.159)
1.79
(0.159)
353

$0.33M

$7.3M
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Figure 10
Age Distribution of HMB Women Admitted to Hospital

The age distribution of hospitalized women with comorbidities was examined.
Tables 23 and 24 compares ED versus hospitalized women by comorbidity. A secondary
diagnoses of anemia, diabetes, and hypertension are summarized in Table 23.
Comorbidities of headache, nausea, low back pain, and depression are summarized in
Table 24. Incidence rates most comorbidities were significantly different in hospitalized
women in each age group.
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Table 21
Comparison Between ED and Hospital Admission (NRD) HMB Cohorts Based on
Primary Comorbidities Anemia, Hypertension, and Diabetes by Age Group
Age

Comorbidity
Anemia
Hypertension
Diabetes
1
1
ED
NRD
ED
NRD
ED
NRD1
Incidence Incidence Incidence Incidence Incidence
Incidence
N
95% CI
N
N
N
N
95% CI
N
95% CI
95% CI
95% CI
95% CI
10-19
3.00
9.55*
0.37
0.27
0.24
0.53
415
36
51
1
32
2
2.71 6.690.27-0.48 0.00-1.48 0.16-0.33
0.06-1.92
3.30
13.33
20-29
2.80
6.51*
1.19
2.57*
0.46
0.45
1,243
86
530
34
204
6
2.64 –
5.20-8.03 1.09-1.30 1.78-3.59 0.40-0.53
0.17-0.99
2.96
30-39
4.52
4.70
3.29
4.76*
0.97
0.83
1,261
243
919
246
271
43
4.37 4.13-5.33 3.08-3.51 4.19-5.40 0.85-1.09
0.60-1.12
4.88
40-49
7.41
5.14*
5.72
7.25*
1.35
1.13
1,426
455
1100
642
259
100
7.03 4.68-5.64 5.38-6.01 6.70-7.84 1.19-1.52
0.92-1.37
7.81
50-60
6.38
4.78*
9.59
9.88
1.98
1.19*
387
104
582
215
120
26
5.76 –
3.90-5.79
8.838.601.64-2.37
0.78-1.75
7.05
10.71
11.23
*
1 unadjusted for NEDS population representation
significant difference ED versus
NRD
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Table 22
Comparison Between ED and Hospital Admission HMB Cohorts Based on Secondary
Comorbidities Headache, Nausea, Low Back Pain, and Depression by Age Group
Age
Headache
ED
Incid
N
95% CI

NRD
Incid
N
95% CI

Comorbidity
Nausea
Low Back
Pain***
ED
NRD
ED
Incid
Incid
Incid
N
N
N
95% CI
95%
95% CI
CI
1.61
NA
0.35
93
0
49
0.70-2.52
0.26-0.46

Depression
ED
Incid
N
95% CI

NRD
Incid
N
95% CI

0.54
1.33**
0.40
NA**
75
5
55
2
0.430.430.30-0.52
0.68
3.10
20-29
0.55
0.38**
0.68
NA
0.46
0.33
1.06*
245
5
303
0
205
145
14
0.480.120.18-1.18
0.40-0.53 0.28-0.38 0.58-1.78
0.62
0.88
30-39
0.57
0.04**
0.48
0.08**
0.51
0.40
1.28*
158
2
135
4
138
110
66
0.480.000.41-0.57 0.020.42-0.58 0.32-0.47 0.99-1.62
0.66
0.14
0.20
40-49
0.55
0.06**
0.34
0.07**
0.40
0.43
1.11*
105
5
66
6
76
83
98
0.440.020.27-0.44 0.020.31-0.49 0.34-0.53 0.90-1.35
0.66
0.13
0.15
**
50-60
0.43
0.09
0.21
0.14**
0.53
0.31
1.10*
26
2
13
3
32
19
24
0.280.010.11-0.37 0.030.36-0.74 0.19-0.49 0.71-1.64
0.63
0.33
0.40
*
**
Significant difference, P < 0.05
Cell number too small for a meaningful
10-19

comparison
***

Low back pain NRD total cohort N =10, therefore no meaningful comparisons could

be made
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Table 23
Incidence Rate Ratio Comparisons of Significant Hospital Admission (NRD) Versus ED
Comorbidity

Anemia

Hypertension

Diabetes
Depression

Age Range

Incidence Rate
Ratio

10-19
20-29
30-39
50-59
20-29
30-39
40-49
50-59
20-29
30-39
40-49
50-60

3.19
2.33
0.69
0.75
2.16
1.45
1.26
0.60
3.25
3.53
2.57
3.52

95%
confidence
interval
2.20 to 4.49
1.85 to 2.90
0.62 t0 0.77
0.60 to 0.93
1.48 to 3.05
1.25 to 1.67
1.15 to 1.40
0.38 to 0.93
1.73 to 5.63
2.55 to 4.86
1.90 to 3.48
1.85 to 6.80

P-value

< 0.001
<0.001
0.009
0.009
<0.001
<0.001
<0.001
0.0184
<0.001
<0.001
<0.001
<0.001

The majority of women with HMB (95.8%) admitted to the hospital did not have a
procedure performed, Table 26. The remaining patients had between 1 to four procedures
performed. Of these women, 240 had a secondary diagnosis (ICD-10-CM code D50.9) of
iron deficiency anemia. Their mean age was 40.06 years, median age 42.50, Figure 12.
Table 24
Core Procedures Performed on HMB Patient While Admitted to Hospital
Number
0
1
2
3
4
Total

Frequency
17147
397
314
45
9
17894

Percent
95.8
2.1
1.8
0.3
0.1
100.0

Cumulative percent
95.8
97.9
99.7
99.9
100.0

108
Figure 12
Anemia Distribution Among HMB ED Cohort
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Table 25
Most Frequent DRG in Effect at Discharge Date
DRG Code Description
743
Uterine and adnexa procedures for nonmalignancy with complication or
comorbidity (CC) / major complication or
comorbidity (MCC)
742
Uterine and adnexa procedures for nonmalignancy without complication or
comorbidity (CC) / major complication or
comorbidity (MCC)
760
Menstrual and other female reproductive
system disorders with CC/MCC
761
Menstrual and other female reproductive
system disorders without CC/MCC
744
D&C conization, laparoscopy with
CC/MCC
745
D&C conization, laparoscopy without
CC/MCC
Total

Frequency
9289

Percentage
51.9

3357

18.8

2165

12.1

1454

8.1

839

4.7

509

2.8

17,613

98.4

Binary Logistic Regression Model
Binary logistic regression will model the binary outcome (hospitalization or not)
using categorical and continuous predictor (independent) variables. Logistic regression
will predict the probability of Y materializing given known values of the predictor
variable (Field, 2015). The logarithmic transformation (logit) of the linear equation
addresses the assumption of independent variable linearity, Equation 4.1.
1
P(Y) =

1 + е –(b0 + b1X1i + b2X2i + …. bnXni)

(4.1)
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In which b0 is a constant, Xi is the predictor variable, and the predictor coefficient is bi.
Logistic regression uses maximum likelihood estimation to determine bi. The logistic
regression model was developed using a backward stepwise method. With the theorydriven approach, the model was developed with the aim for parsimony.
The model aimed to estimate the risk of being admitted to the hospital, based on
health comorbidities present, anemia, diabetes, and hypertension. Four logistic regression
models were developed. The initial model included all of the HMB cohort, N = 129,449.
Variables included in the initial model included both categorical (primary payer, median
household income, and patient location) and continuous variables (age). Categorical
variables that did not contribute to the model and were dropped include the month of
admission, weekend admission, and the quarter of the event.
Logistic regression analysis of the entire HMB cohort identified nine significant
predictor variables, Table 28. Age was associated with an increase in the risk of
hospitalization for each year of age. The odds ratio for age 1.091 translates to odds of
being hospitalized increases by 9% per year, or approximately by 90% per decade. This is
consistent with the significant difference in mean age between ED and hospitalized
women. Each patient location was included in the logistic regression model, where
hospitalization risk was less regardless of location. The model found that women of the
middle-income quartiles were more likely to be hospitalized.
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Table 26
Coefficients of the Model Predicting Hospital Admission for the HMB Cohort

Included
Constant
Age

b
-4.47
(-4.61 to -4.34)
0.087
(0.085 to 0.089)
.47
(to 0.56)
-0.97
(-1.04 to 0.90)
-0.64
(-0.72 to -0.57)
-0.39
(-0.46 to -0.32)
-0.45
(-0.54 to -0.35)
-0.29
(-0.38 to -0.20)
.090
(0.84 to 0.15)

Sig

<0.001

95% CI for Odds Ratio
Lower
Odds
Upper

1.089

1.091

1.093

Private
<0.001
1.448
1.592
1.752
insurance
Large central
<0.001
0.379
0.379
0.409
metropolitan
Large fringe
<0.001
0.486
0.526
0.570
metropolitan
Medium
<0.001
.631
0.681
.735
metropolitan
Small
<0.001
0.588
0.641
0.700
metropolitan
Mirco<0.001
0.688
0.751
0.720
metropolitan
Median
0.002
1.033
1.094
1.159
household
income: $43K$53.9K
Median
.15
<0.001
1.158
1.094
1.227
household
(0.09 to 0.21)
income: $54K$70.9K
Note. R2 = 0.121, Cox & Snell R Square = 0.127, and Nagelkerke R Square = 0.229
The logistic regression model for women with a secondary diagnosis of anemia
included four significant predictor variables, Table 29. Age was associated with an
increase in the risk of hospitalization for increasing age. The odds ratio for age 1.052
translates to odds of being hospitalized increases by 5% per year of age or approximately
by 50% per decade. For the primary payer predictor variable only, private insurance was
significant. The odds ratio of 1.58 predicts that women who were hospitalized are 58%
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more likely to have private insurance. The only patient locations that were significant
were large central and fringe metropolitan areas, with odds ratios 0.65 and 0.67
respectively. These odds ratios would predict a reduced risk of being hospitalized for
women who live in the locations categorized as the largest. There were no significant
predictors found for medium household income.

Table 27
Coefficients of the Model Predicting Hospital Admission for the HMB Cohort with
Anemia Diagnosis
95% CI for Odds Ratio
b
Sig
Lower
Odds
Upper
-3.14
(-3.77 to -2.51)
Age
0.051
<0.001
1.044
1.052
1.060
(0.043 to 0.059
Private
0.46
0.026
1.056
1.582
2.369
insurance
(0.07 to 0.85)
Large central
-0.43
0.026
0.443
0.649
0.949
metropolitan
(-0.80 to -0.06)
Large fringe
-.42
0.041
0.437
0.665
0.983
metropolitan
(-0.82 to -0.03)
R2 = 0.068, Cox & Snell R Square = 0.077, and Nagelkerke R Square = 0.122
Included
Constant

The logistic regression model for women with a secondary diagnosis of diabetes
included eight significant predictor variables, Table 30. Age was associated with an
increase in the risk of hospitalization for increasing age. The odds ratio for age 1.055
translates to odds of being hospitalized increases by 6% per year of age or approximately
by 55% per decade. Women who lived in the largest three metropolitan areas were less at
risk for being hospitalized. Those women with dependence on government (Medicare and
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Medicaid) or self-payment was less likely to be hospitalized. No median household
income quartile was a significant predictor of hospitalization.
Table 28
Coefficients of the Model Predicting Hospital Admission for the HMB Cohort with a
Diabetes Diagnosis.
95% CI for Odds Ratio
b
Sig
Lower
Odds
Upper
-2.45
(-3.85 to 1.08)
Age
0.054
<0.001
1.037
1.055
1.077
(0.052 to 0.056)
Large central
-.90
0.012
.202
0.407
0.823
metropolitan
(-1.58 to -0.22)
Large fringe
-1.03
0.008
0.167
0.356
0. 167
metropolitan
(-1.76 to -0.30
Medium
-.80
0.033
0.216
0.451
0.939
metropolitan
(-1.51 to -0.09)
Small
-1.40
0.005
0.092
0.246
0.657
metropolitan
(-2.35 to -0.45)
Medicare
-1.49
0.009
0.074
0.225
0.686
(-2.57 to -0.41)
Medicaid
-0.86
0.044
0.183
0.423
0.977
(-3.37 to -0.05)
Self-pay
-1.70
0.002
0.63
0.018
0.534
(-2.74 to -0.96)
R2 = 0.031, Cox & Snell R Square = 0.04, and Nagelkerke R Square = 0.067
Included
Constant

The logistic regression model for women with a secondary diagnosis of
hypertension included nine significant predictor variables, Table 31. Age was associated
with an increase in the risk of hospitalization for increasing age. The odds ratio for age
1.048 translates to odds of being hospitalized increases by 5% per year of age or
approximately by 50% per decade. Each patient location was included in the logistic
regression model, where hospitalization risk was less regardless of location. Women who
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had private insurance or were not charged had a greater likelihood of being hospitalized,
whereas those who had to self-pay had a significantly less likelihood of being
hospitalized. None of the median household income quartiles was included in the model.

Table 29
Coefficients of the Model Predicting Hospital Admission for the HMB Cohort with a
Hypertension Diagnosis

Included
Constant

95% CI for Odds Ratio
Lower
Odds
Upper

b
Sig
-2.44
(-3.08 to -1.80)
Age
0.047
<0.001
1.039
1.048
(0.039 to 0.055)
Large central
-1.04
<0.001
0.258
0.352
metropolitan
(-1.34 to -0.74)
Large fringe
-0.67
<0.001
0.368
0.514
metropolitan
(-0.99 to -0.35
Medium
-0.52
0.002
0.431
0.595
metropolitan
(-0.85 to -0.20
Small
-0.64
0.001
0.365
0.529
metropolitan
(-1.00 to -0.28)
Micro-0.49
0.008
0.425
0.611
metropolitan
(-0.84 to -0.14)
Private
0.48
0.026
1.059
1.617
insurance
(0.07 to 0.89)
Self-pay
-0.91
<0.001
0.247
0.402
(-1.38 to -0.44)
No charge
1.04
0.005
1.367
2.818
(0.34 to 1.74)
R2 = 0.069, Cox & Snell R Square = 0.079, and Nagelkerke R Square = 0.115

1.057
0.481
0.718
0.821
0.766
0.979
2.467
0.654
5.806

All four logistic regression models found age to be a significant contributor to
being hospitalized, Table 32. For each year, the risk of being hospitalized increased. For
the whole cohort, each decade of reproductive life increased risk by 90%. For women
with anemia, hypertension, or diabetes the risk increased by 50% for each decade. These
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odds ratios were all significant. The interpretation of these odd ratios supports the theory
that unattended bleeding in the early years of life is not without health consequences.
Table 30
Odds Ratio for Age in the Four Logistic Regression Models
Model
Whole HMB Cohort

b
0.087

Odd Ratio
1.091

Anemia

0.051

1.052

Hypertension

0.047

1.048

Diabetes

0.054

1.055

95% CI
1.089 –
1.093
1.044 –
1.060
1.039 –
1.057
1.037 –
1.077

P
<0.001
<0.001
<0.001
<0.001

Summarizing the logistic regression models for comorbidities did reveal
differences in hospitalization risk. Women with private insurance regardless of the model
examined were all more likely to be hospitalized, Table 33. The exception was diabetes.
Women with diabetes regardless of insurance were less likely to be hospitalized.
Table 31
Odds Ratio of Hospitalization with Private Insurance
Model
Whole HMB Cohort
Anemia
Hypertension
Diabetes

b
0.47
0.46
0.48

Odds Ratio
1.592
1.582
1.617
NS

95% CI
1.448 – 1.752
1.056 – 2.369
1.059 – 2.467

P
<0.001
0.026
0.026

Research Question 3
RQ3: What is the association between location and economic status (see Song et al.
2010) and ED presentation for HMB?
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H03: There is no association between location and economic status and presentation to
the emergency room for women of reproductive age in the United States.
Ha3: There is an association between location and economic status and presentation to
the emergency room for women of reproductive age in the United States.
A discriminant analysis was conducted to ascertain whether location as a
predictor would identify differences in the HMB cohort for the independent variables
median household income, primary payer, and age. Four discriminant analyses was
performed, on the entire HMB cohort, and for the three comorbidities anemia, diabetes,
and hypertension. Distribution by location is described in Table 34 and Figure 13.
Table 32
Sample Size by Location
Location
Large central
metropolitan
Large fringe
metropolitan
Medium metropolitan
Small metropolitan
Micropolitan
Not micropolitan (rural)
Total

Definition
Central counties of metro areas of > =1 million

N
46,612

Fringe counties of metro areas of >=1 million

27,003

Counties in metro areas of 250,000-999,999
Counties in metro areas of 50,000-249,999
Counties in metro areas of 25,000-49,000
Counties less than 24,999

26,417
11,769
10,702
6,636
129,138
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Figure 13
Anemia Distribution Among HMB ED Cohort

HMB Cohort
Women in the entire HMB cohort, the overall Wilks’s lambda was significant, Λ
= 0.889, χ2 (15, N=127,539) = 14964.44, P < 0.001. Two additional functions were also
significant. In addition, the residual Wilks’s lambda was significant. This test suggested
that the independent variables or predictors differentiated significantly among the six
locations. Table 35 summarizes the within-groups correlations between the independent
(predictors) and the discriminant functions.
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Table 33
Standardized Coefficients and Correlations of Predictor Variables with Three
Discriminant Functions for HMB Cohort

Predictors
Median
income
Primary
Payer
Age

Correlation coefficients with
discriminant functions
Function
Function
Function
1
2
3
0.999
-0.23
-0.27

Standardized coefficients for
discriminant functions
Function
Function
Function
1
2
3
.997
0.01
-0.13

0.06

0.87

0.49

0.03

0.88

0.48

0.12

-0.48

0.87

0.13

-0.49

0.88

Based on the coefficients, the median household income by quartile had the
strongest association based on the first discriminant function. The primary payer was the
strongest in the second function and age in the third. Women living in the largest urban
areas (large central metropolitan, and large fringe metropolitan) (M = 0.39 and 0.61
respectively) were most likely to be admitted to hospital. The lowest median household
income was the best predictor of hospitalization regardless of patient location. The
percentage of women hospitalized by income and location is described in Table 36.
Overall, the lowest income group was twice as likely to require hospitalization 34.2%
versus the highest 16.4%, N = 6,019 and 2876 respectively. Across each location, the
poorest women represented the greatest proportion of those admitted except for women
living in the fringe large metropolitan regions.
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Table 34
Hospitalization by Income and Location

Large
central
metropolitan
Large fringe
metropolitan

Count
Expected
% within
Count
Expected
% within
Medium
Count
metropolitan Expected
% within
Small
Count
metropolitan Expected
% within
Micropolitan Count
Expected
% within
Rural
Count
Expected
% within
Total
Count
Expected
% within

Median Household Income
$1-42.9K
$43K$54K53.9K
70.9K
1577
1103
1118
1621.9
1259.5
1082.7
33.3%
23.3%
23.6%
660
867
1152
1340.9
1041.3
895.1
16.8%
22.1%
29.4%
1351
1190
1081
1433.6
1113.3
957.0
32.3%
28.4%
25.8%
621
568
385
568.5
441.4
379.5
37.4%
34.2%
23.2%
942
606
168
594.5
461.6
396.8
54.2%
34.9%
9.7%
868
340
114
459.6
356.9
306.8
64.6%
25.3%
8.5%
6019
4674
4018
6019.0
4674.0
4018.0
34.2%
26.6%
22.8%

$71K+

Total

941
775.0
19.9%
1239
640.7
31.6%
567
685.0
13.5%
87
271.6
5.2%
21
284.1
1.2%
21
219.6
1.6%
2876
2876.0
16.4%

4739
4739.0
100.0%
3918
3918.0
100.0%
4189
4189.0
100.0%
1661
1661.0
100.0%
1737
1737.0
100.0%
1343
1343.0
100.0%
17587
17587.0
100.0%

Determinants of health include income status and location. The median household
income quartile by ZIP code indicates that this group of women come primarily from
low-income settings. The lowest income category was disproportionately represented in
the HMB cohort, 39.59%. All comparisons versus the next three quartiles were
significantly different, Table 37 strengthening the finding that median household income
is an important determinant of women’s health.
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Table 35
Comparisons of Median Household Income Quartiles
Median
Income

$1-$42,999
Difference
P value
95% CI (%)
-

$1-$42,999

$43,000$53,999
Difference
P value
95% CI (%)
13.37%
<0.0001
12.69-14.05
-

$43,000$53,999

$54,000$70,999
Difference
P value
95% CI (%)
19.97
<0.0001
19.27 - 20.66
6.60%
<0.0001
5.87 - 7.33
-

$54,000$70,999
$71,000 +

$71,000 +
Difference
P value
95% CI (%)
26.30%
<0.0001
25.58 - 27.01
12.93%
<0.0001
12.18 - 13.67
6.33%
<0.0001
5.57 - 7.09
-

Anemia as a Secondary Diagnosis Cohort
The Women in the entire HMB cohort, the overall Wilks’s lambda was
significant, Λ = 0.903, χ2 (15, N=5,569) = 565.74, P < 0.001. Two additional functions
were also significant. The residual Wilks’s lambda was significant. This test suggested
that the independent variables or predictors differentiated significantly among the six
locations, Table 38 summarizes the within-groups correlations between the independent
(predictors) and the discriminant functions.
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Table 36
Standardized Coefficients and Correlations of Predictor Variables with the
Three Discriminant Functions for Anemia Comorbidity Cohort

Predictors
Median
income
Primary
Payer
Age

Correlation coefficients with
discriminant functions
Function
Function
Function
1
2
3
1.006
-0.008
0.002

Standardized coefficients for
discriminant functions
Function
Function
Function
1
2
3
0.994
-0.013
0.108

0.004

0.997

0.084

0.008

0.993

0.115

-0.109

-0.115

0.994

-.002

-0.084

0.996

Figure 14
Anemia Distribution Among HMB ED Cohort
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Table 37
HMB with Anemia Hospitalization by Income and Location

$1-42.9K
Large
central
metropolitan
Large fringe
metropolitan

Count
Expected
% within
Count
Expected
% within
Medium
Count
metropolitan Expected
% within
Small
Count
metropolitan Expected
% within
Micropolitan Count
Expected
% within
Rural
Count
Expected
% within
Total
Count
Expected
% within

125
129.2
36.5%
38
72.9
19.7%
77
74.1
39.3%
30
25.3
44.8%
39
23.8
61.9%
33
16.6
75.0%
342
342.0
37.8%

Median Household Income
$43K$54K53.9K
70.9K
83
79
84.3
77.1
24.3%
23.1%
43
59
47.6
43.5
22.3%
30.6%
49
45
48.3
44.2
25.0%
23.0%
19
16
16.5
23.9
28.4%
23.9%
19
5
15.5
14.2
30.2%
7.9%
10
0
10.8
9.9
22.7
0.0%
223
204
223.0
204.0
24.6%
22.5%

$71K+

Total

55
51.4
16.1%
53
29.0
27.5%
25
29.5
12.8%
2
10.1
3.0%
0
9.5
0.0%
1
6.6
2.3%
136
136.0
15.0%

342
342.0
100.0%
193
193.0
100.0%
196
196.0
100.0%
67
67.0
100.0%
63
63.0
100.0%
44
44.0
100.0%
905
905.0
100.0%

Based on the coefficients, the median household income by quartile had the strongest
association based on the first discriminant function. The primary payer was the strongest
in the second function and age in the third. Women living in the largest urban areas (large
central metropolitan, and large fringe metropolitan) (M = 0.34 and 0.51 respectively)
were most likely to be admitted to hospital. The lowest median household income was
the best predictor of hospitalization for women with anemia as comorbidity regardless of
patient location. The percentage of women hospitalized by income and location is
described in Table 39. Overall, the lowest income group were 2.5 times more likely to
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require hospitalization 37.8% versus the highest 15.0%, N = 342 and 136 respectively.
Across each location, the poorest women represented the greatest proportion of those
admitted except for women living in the fringe large metropolitan regions, Figure 14.
Diabetes as a Secondary Diagnosis Cohort
The Women in the diabetes comorbidity HMB cohort, the overall Wilks’s lambda
was significant, Λ = 0.878, χ2 (15, N = 1,052) = 136.31, P < 0.001. Two additional
functions were also significant. The residual Wilks’s lambda was significant. This test
suggested that the independent variables or predictors differentiated significantly among
the six locations. Table 40 summarizes the within-groups correlations between the
independent (predictors) and the discriminant functions.
Table 38
Standardized Coefficients and Correlations of Predictor Variables with the Three
Discriminant Functions for Diabetes Comorbidity Cohort

Predictors
Median
income
Primary
Payer
Age

Correlation coefficients with
discriminant functions
Function
Function
Function
1
2
3
0.99
-0.09
-0.05

Standardized coefficients for
discriminant functions
Function
Function
Function
1
2
3
0.99
-0.19
-0.05

0.17

0.95

-0.27

0.07

0.26

0.96

0.10

0.23

0.97

0.08

0.97

-0.24
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Table 39
HMB with Diabetes Hospitalization by Income and Location

$1-42.9K
Large
central
metropolitan
Large fringe
metropolitan

Count
Expected
% within
Count
Expected
% within
Medium
Count
metropolitan Expected
% within
Small
Count
metropolitan Expected
% within
Micropolitan Count
Expected
% within
Rural
Count
Expected
% within
Total
Count
Expected
% within

26
21.3
44.1%
4
13.4
10.8%
12
14.5
30.0%
2
2.9
25.0%
10
6.1
58.8%
10
5.8
62.5%
64
64.0
36.2%

Median Household Income
$43K$54K53.9K
70.9K
9
13
16.7
14.7
15.3%
22.0%
14
14
10.5
9.2
37.8%
37.8%
14
12
11.3
9.9
35.0%
30.0%
1
4
2.3
2.0
12.5%
50.0%
6
1
4.8
4.2
35.3%
5.9%
6
0
4.5
4.0
37.5%
0.0%
50
44
50.0
44.0
28.2%
24.9%

$71K+

Total

11
6.3
18.6%
5
4.0
13.5%
2
4.3
5.0%
1
0.9
12.5%
0
1.8
0.0%
0
1.7
0.0%
19
19.0
10.7%

59
59.0
100.0%
37
37.0
100.0%
40
40.0
100.0%
8
8.0
100.0%
17
17.0
100.0%
16
16.0
100.0%
177
177.0
100.0%

Based on the coefficients, the median household income by quartile had the
strongest association based on the first discriminant function. The primary payer was the
strongest in the second function and age in the third. Women living in the largest urban
areas (large central metropolitan, and large fringe metropolitan) (M = 0.19 and 0.59
respectively) were most likely to be admitted to hospital. The lowest median household
income was the best predictor of hospitalization for women with diabetes as a
comorbidity for rural and micropolitan locations. The percentage of women hospitalized
by income and location is described in Table 41. Overall, the lowest income group were
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three times more likely to require hospitalization 36.2% versus the highest 10.7%, N = 64
and 19 respectively. Across each location, the poorest women represented the greatest
proportion of those admitted except for women living in the fringe large metropolitan
regions, Figure 15. A note of caution in the interpretation should be exercised, as the
number of patients in several of the individual cells (Table 41) are less than 10 subjects.
Figure 15
Anemia Distribution Among HMB ED Cohort

Hypertension as a Secondary Diagnosis Cohort
The Women in the diabetes comorbidity HMB cohort, the overall Wilks’s lambda
was significant, Λ = 0.852, χ2 (15, N = 1,121) = 679.20, P < 0.001. Two additional
functions were also significant. The residual Wilks’s lambda was significant. This test
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suggested that the independent variables or predictors differentiated significantly among
the six locations. Table 42 summarizes the within-groups correlations between the
independent (predictors) and the discriminant functions.
Table 40
Standardized Coefficients and Correlations of Predictor Variables with the Three
Discriminant Functions for Hypertension Comorbidity Cohort

Predictors
Median
income
Primary
Payer
Age

Correlation coefficients with
discriminant functions
Function
Function
Function
1
2
3
1.02
-0.15
-0.03

Standardized coefficients for
discriminant functions
Function
Function
Function
1
2
3
0.996
-0.14
-0.03

0.01

0.11

0.98

0.01

0.11

0.995

0.00

0.11

-0.01

0.03

1.00

-0.11

Based on the coefficients, the median household income by quartile had the
strongest association based on the first discriminant function. The primary payer was the
strongest in the second function and age in the third. Observed patterns for the whole
HMB cohort and the anemia and diabetes comorbidity were consistent. The Theory of
Reasoned Action would predict that all health dimensions should exhibit a similar pattern
of attention. Women living in the largest urban areas (large central metropolitan, and
large fringe metropolitan, M = 0.17 and 0.68 respectively) were most likely to be
admitted to hospital.
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Table 41
HMB with Hypertension Hospitalization by Income and Location

$1-42.9K
Large
central
metropolitan
Large fringe
metropolitan

Count
Expected
% within
Count
Expected
% within
Medium
Count
metropolitan Expected
% within
Small
Count
metropolitan Expected
% within
Micropolitan Count
Expected
% within
Rural
Count
Expected
% within
Total
Count
Expected
% within

123
125.4
39.8%
44
105.5
16.9%
110
102.3
43.7%
44
40.2
44.4%
67
44.2
61.5%
67
37.3
72.8%
455
445.0
40.6%

Median Household Income
$43K$54K53.9K
70.9K
82
55
80.5
60.1
26.5%
17.8%^
58
78
67.7
50.6
22.3%
30.0%
68
51
65.6
49.0
27.0%
20.2%
31
20
25.8
19.3
31.3%
20.2%
32
10
28.4
21.2
29.4%
9.2%
21
4
24.0
17.9
22.8%
4.3%
292
218
292.0
218.0
26.0%
19.4%

$71K+

Total

49
43.0
15.9%
80
36.2
30.8%
23
35.1
9.1%
4
13.8
4.0%
0
15.2
0.0%
0
12.8
0.0%
156
156.0
13.9%

309
309.0
100.0%
260
260.0
100.0%
252
252.0
100.0%
99
99.0
100.0%
109
109.0
100.0%
92
92.0
100.0%
1121
1121.0
100.0%

The lowest median household income was the best predictor of hospitalization for
hypertensive women regardless of patient location. The percentage of women
hospitalized by income and location is described in Table 43. Overall, the lowest income
group were three times more likely to require hospitalization 40.6% versus the highest
13.9%, N = 445 and 156 respectively. Across each location, the poorest women
represented the greatest proportion of those admitted except for women living in the
fringe large metropolitan regions, Figure 16. In the smallest two locations, the poorest
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women (median household income below $42,999) represented 64.6% of hospitalized
patients.
Figure 16
Hypertension Distribution Among HMB ED Cohort

Summary
The inclusion criteria extracted 111,555 women with HMB from the NEDS
database. From the NRD database 17,894 women were admitted to hospital. Three
research questions were addressed by this study. Question one examined the association
between demographic (age), health status, (anemia), insurance status and emergency
department outcome (hospital admission, Y/N) for heavy menstrual bleeding. Women
who were admitted to hospital were older than those who presented to the ED and were
released. The older women were more likely to present with a secondary diagnosis of
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anemia. They had a significantly great prevalence of anemia than the general population.
One-third of the women with anemia had Medicaid as their primary insurance.
Question two examined the association between health factors (comorbidities
such as diabetes and hypertension) admission for menorrhagia, and emergency
department outcome (hospital admission, Y/N) for heavy menstrual bleeding. The logistic
regression models found age to be a significant predictor of hospitalization for all three
comorbidities modeled; anemia, diabetes, and hypertension. Women with private
insurance were more likely to be hospitalized regardless of comorbidity.
Research question three examined the association between location (spatial), and
economic status and outcome (hospital admission, Y/N) for heavy menstrual bleeding.
The lowest median household income was the best predictor of hospitalization regardless
of comorbidities. Women living in the smallest rural locations with the lowest median
household income were hospitalized with a substantially greater frequency than women
living in larger metropolitan areas were.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
HMB represents a physical and psychosocial challenge throughout the
reproductive years. The TRA posits that the decision to address this health issue of
excessive menstrual bleeding via a presentation at the ED is a health-seeking behavior
initiated by profound individual concern. Analysis of the NEDS and NRD databases
found a substantial number of women with HMB. The cohort identified via a presentation
to the ED was N = 111,555. In the NEDS dataset, each record was assigned a weight. The
weight was recorded in the core data element DISCWT. When the discharge weights
were applied to the unweighted NEDS observations, the result was an estimate of the
number of nationwide ED visits. Applying the weights resulted in a national estimate of
509,833 ED visits for HMB in 2016.
Hospitalized women with a primary diagnosis of HMB identified in NEDS
equaled 17,894. Estimating nationwide hospitalizations for HMB translated to a probable
34,344 admissions in 2016. This rate of hospitalization is not inconsequential. Combined
with the estimated half-million nationwide ED visit estimates, these counts support the
premise that HMB is both an important women’s health issue and a public health
concern. Understanding determinants that contribute to both ED presentation and
hospitalization provide context and potential opportunity for efforts aimed at reduction of
the population burden.
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Heavy Menstrual Bleeding Cohort Demographics
Previous reports have suggested that HMB may be more prevalent among
women in their midreproductive years. An estimate of the overall prevalence in France is
between 11% to 13%. This increases with age, reaching a reported peak prevalence of
24% among women aged 36 to 40 years (Marret et al., 2010). The HMB cohort who
presented at the ED was aged 30.89 years (SD 10.37), see Figure 4. This mean age, while
younger than the peak reported previously, supports the premise that women frequently
wait until HMB impedes daily activities or hinders their quality of life before seeking
treatment (Copher et al., 2013).
The age distribution is positively skewed, indicating an increased frequency of
cases in younger women. The skewness coefficient was +0.517. The median age was
29.00, and the mode was 22 (N = 6,197) years. Kurtosis was -0.517, indicating a flatter
platykurtic curve describing the distribution. An examination of seasonal distribution did
not reveal patterns suggestive of higher frequency of ED presentation by a quarter of the
year or month. The frequency of coming to the ED during the weekends 25.4% was
lower than expected, p < 0.0001, (z-statistic = 11.91, 95% CI: 24.89% to 25.91%). The
slight excess of weekday presentations is consistent with the theory that the ED is
fulfilling a primary care function.
Ascertaining an appreciation of the overall health involved an examination of
patient disposition, concurrent diagnoses, and mortality. Once in the ED, the majority of
women were treated and released, 94.8%. This cohort had multiple diagnoses, with over
70% of the women having one to four additional health concerns, see Figure 5. The high
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frequency of multiple health problems suggests that those who come to the ED for HMB
presentation carry additional health burdens. The death rate was very low, with six deaths
recorded in these women. The cause of death was not available. Thus, while mortality is
infrequent, the apparent health burden based on concurrent diagnoses suggests that these
women may indeed delay health seeking behaviors and actions.
Determinants of health include income status and location. The median household
income quartile by ZIP code indicates that this group of women comes primarily from
low-income settings. The lowest income category was disproportionately represented in
the HMB cohort, 39.59%. All comparisons versus the next three quartiles were
significantly different, see Table 37. The majority of these women lived in large
metropolitan locations. Those living in locations classified as metropolitan represented
58.71% of the cohort. Those living in rural settings or micropolitan (small to mediumsized towns) represented 12.61% of the study population. Understanding the reasons for
this disproportionate distribution was not possible. When looking at the entire 2016
NEDS population where the location was reported (missing data excluded; N =
32,508,694), 16.00% of the ED cases came from rural and micropolitan regions. The
contribution of large metropolitan regions was 54.51%, slightly less than the HMB
cohort.
Economic costs associated with ED visits are not trivial. The median charge was
$2,486 (range $100 to $127,317). The mean cost was $3,373, and the mode was $2,150.
For this cohort total, ED costs recorded was $325.8 million. For comparison, the median
cost for the entire NEDS 2016 population (N = 27,930,718) was $2,007, the mean
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was$3,359, and the mode was $1,303. This suggests that these patients incurred slightly
greater costs than other patients who present at the ED.
Research Question 1
The association between demographic (age), health status (anemia), insurance
status, and ED presentation for HMB was examined to ascertain the impact of chronic
blood loss manifested as anemia. Anemia was extracted as a secondary diagnosis using
the ICD-10 code D64.9. The filter identified 4,731 (4.24%) HMB women with a
secondary diagnosis of anemia. The frequency of anemia increased with increasing age,
see Figure 6. The mean age of this group was 34.81 years (SD = 10.83). The mean
difference versus the whole HMB cohort was 3.92 years, which was significantly
different, p < 0.0001 (95% CI: 3.62 to 4.22). The greatest incidence of anemia was in
women aged 40 to 49 years, 7.41%. The null hypothesis (H01) was rejected: There is no
statistically significant association between demographic factors (age), health status
(anemia), insurance status, and presentation to the emergency room for women of
reproductive age in the United States.
Women with anemia used primarily three forms of insurance. Medicare, private
insurance, and self-pay represented 92.67% of the primary payment used. There were
significantly more women on Medicare versus the other insurance. The differences
between women whose primary payment was Medicare (38.10%) were significantly
different greater than private insurance (34.26%), difference 3.84%, and p = 0.0196 (95%
CI: 0.61% to 7.05%). A significant difference was also observed between Medicare
versus self-pay (30.47%), difference 7.63%, p < 0.0001 (95% CI: 4.35% to 10.87%). The
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difference between private insurance and self-pay 3.79% was also significant, p = 0.025
(95% CI: 0.47% to 7.09%).
In addition to testing the hypothesis via ANOVA, further support for the Ha1) was
found when the HMB cohort was compared to a recent analysis of the NHANES 2016
(Le, 2016) cohort of women, see Table 15. The anemia prevalence between NHANES
and the HMB was significantly different in the three oldest age groups. The TRA posits
that women seeking health support in the ED have accrued a substantial physical and
psychosocial burden. Anemia as a sentinel health marker for chronic blood loss was
expected to be more prevalent among women with HMB. The findings that age is
associated with a greater frequency of anemia supports the theory that there is an
accumulation of health deficits over time. Combined with a significantly greater
Medicare presence, this suggests economic disadvantage among women who present at
the ED.
Research Question 2
Several health factors may be important determinants associated with HMB.
Comorbidities such as diabetes and hypertension were selected as broad health indicators
for general wellness. Specific comorbidities for HMB including headache, nausea, low
back pain, and depression were also examined for their contribution to ED presentation
for HMB. I examined the hypothesis that there is no association between health factors
(comorbidities such as diabetes and hypertension) and presentation to the emergency
room for women of reproductive age in the 30 states participating in the NEDS United
States. The frequency of these comorbidities is listed in Table 18. Physical comorbidities
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headache, nausea, low back pain, and depression were all infrequent, less than 0.5% of
the secondary diagnoses of these women. This low rate was unexpected but maybe a
reflection of an ED provider being focused on the primary symptom at presentation. A
comparison of the comorbidities incidence in the ED and treat and release cases with
women admitted to the hospital is summarized in Table 22 and Table 23. These tables
also summarize the comparisons for each comorbidity by age strata. As tabulated in
Table 24, women in the youngest age categories were more likely to be admitted to the
hospital. This was most pronounced in the youngest age category of 10 to 19 years, with
an incidence rate ratio of 3.19, p < 0.001 (95% CI: 2.20 to 4.49). This may be a reflection
of more intensive treatment for adolescent girls versus older women. Exploring the
association between age in women with blood loss, three important surrogate markers
were examined: anemia, iron deficiency, and those who received a transfusion. The
association revealed a progressive and significant increase in each blood loss category by
age (versus the whole cohort), see Table 20. This supports the findings that the
hematological burden of heavy periods accumulates over reproductive years.
Diabetes did not appear to have a strong association in either ED presentation (N
= 841, 0.75%) or hospitalization (N = 177, 0.99%); the difference was not significant.
The theory of overall poor health associated with delayed health-seeking behavior was
not evident with this comorbidity. A potential explanation is a bias towards documenting
the primary complaint. Additionally, diabetes is a chronic condition, so unless a patient is
in crisis, they would likely not be recorded in the presence of an excessive bleeding
event.
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Hypertension was associated with hospitalization in women ages 20 to 49. Across
the three age strata (20-29, 30-39, and 40-49), women hospitalized were significantly
more likely to be hypertensive than women who were treated and released from the ED.
This comorbidity was more prevalent in the HMB cohort, N = 3,194 (2.86%) than
diabetes. The near four-fold difference suggests that this comorbidity might be a better
measure of wellness than diabetes.
To assess risk associated with comorbidities, a logistic regression model was
developed using a backward stepwise method. A primary aim was to estimate the risk of
being admitted to the hospital based on health comorbidities present, anemia, diabetes,
and hypertension. The model was developed with the aim of parsimony. This resulted in
trimming the variables included in the primary payer, median household income, and
patient location (categorical) as well as age (continuous). Four models were run: for the
HMB cohort (N = 129,449), anemia (N = 6,328), hypertension (N = 5,535), and diabetes
(N = 1,199).
All four logistic regression models found age to be a significant contributor to
being hospitalized, Table 32. For each year, the risk of being hospitalized increased. For
the whole cohort, each decade of reproductive life increased risk by 90%. For women
with anemia, hypertension, or diabetes the risk increased by 50% for each decade. These
odds ratios were all significant. The interpretation of these odd ratios supports the theory
that unattended bleeding in the early years of life is not without health consequences.
The regression models found signals associated with both patient location, type of
insurance, and median household income. In the overall HMB cohort, women who lived
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in large metropolitan areas were less likely to be hospitalized, odds ratio of less than 1.0.
This would suggest several possible potential explanations. First, women who live in
large metro areas may have access to specialized care that may mitigate the severity.
Second, in large metro areas, ED services may be sufficiently comprehensive to result in
a greater proportion of women to be treated and released. Women with private insurance
regardless of the model examined were all more likely to be hospitalized, Table 33.
Interestingly, in the diabetes comorbidity model, women with Medicare as their primary
insurance coverage were 42% less likely (Odds ratio = 0.423) to be hospitalized (p =
0.044, 95% CI: 0.18 to 0.98). This may indicate a bias towards insurance coverage,
financial capabilities, or overall economic resources. Finally, higher household income
quartiles were consistently more likely to be hospitalized. These findings support the
theory that while access barriers to the ED may be low, those who are admitted require
greater economic resources to gain access.
The null hypothesis that there is no association between health factors
(comorbidities such as diabetes, and hypertension) and presentation to the emergency
room was rejected. Women are at greater risk for hospitalization as they age during
reproductive years. Those with higher income and private insurance also appear to
receive more intensive care as assessed by hospitalization risk. These findings support the
theory that health avoidance behavior increases health burden and that in later life a
tipping point for action is reached.
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Research Question 3
Exploring the association between patient locations as a surrogate for diagnostic
intensity was the final analysis. The theory posits that women located in larger
metropolitan areas may have greater resources available to them. This will include
specialized providers’ who will be able to provide expert care and be able to make
accurate diagnoses in the face of excessive bleeding symptoms (Song, et al. 2010). This
research question further explores the association between location and presentation to
the emergency room for women of reproductive age in the USA.
As a follow up to the significant findings in research question one, discriminant
analysis was used to predict if the location (grouping variable) with independent
variables, primary payer, median household income, and age predicted hospitalization.
Women who were hospitalized in the HMB cohort were most likely to live in large
metropolitan areas. These areas are defined as having populations greater than 1 million
people. Low median income was also a significant predictor of hospitalization. The
proportion hospitalized in the lowest household income group was significantly greater
versus each of the other three quartiles, p < 0.001. Women living in the smallest locations
(population less than 25,000) and with the lowest household income had the highest
proportion of hospitalizations among this cohort, Table 36. Additionally, transportation
barriers may also contribute to women delaying seeking medical care (Wolfe et al.,
2020). This finding may suggest that in the rural locations where transportation barriers
are greater for poor women and expert care may be limited or not available, treatment in
the ED may not be sufficient to release these women, Figure 13. In the rural location
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64.6% of the low-income (zipinc_qrtl 1) women were hospitalized, double the expected
rate. These findings support the premise that women in areas of limited access to expert
care may be either initially undertreated, or they will delay seeking care until the
symptoms become more serious.
Figure 13 illustrates the finding that there is an increased likelihood that women
who live in the lowest median income quartile were more likely to be hospitalized
regardless of location. One exception to this trend is found in fringe metropolitan
locations. A potential explanation of this finding that the fringe metropolitan locations are
an outlier in this trend could be that these areas, expected to be mostly suburban, may
have an income distribution bias due to the higher cost of living in these urban locations.
Examining Table 36 reveals that in this geographical location Zipinc 1 represents the
fewest cases (16.8%). However, this income stratum represents the largest segment,
39.59% of the total HMB population (Table 12). The smallest geographical areas appear
to have a disproportionate number of low-income women requiring hospitalization. This
supports the premise that place matters. Women with heavy menstrual bleeding who live
in poverty and in rural settings may have the fewest options for early corrective therapies
such as hormone replacement (contraceptives) or anti-fibrinolytic options. The
consequence is that health-seeking behaviors are delayed to the point where ED
interventions may not be effective, and hospitalization is more frequently necessary.
Anemia
Exploring the HMB cohort with a secondary diagnosis of anemia found a similar
trend with the overall HMB cohort. The interest in women with a confirmed secondary
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diagnosis of anemia is that this additional health burden is directly associated with
prolonged and chronic blood loss. Anemia is a late-stage indicator of iron deficiency, one
of the most common nutritional deficiencies in the United States (Sekhar et al., 2017).
From the TRA, women who avoid seeking health for lengthy periods are expected to
develop secondary complications including anemia (Karlsson et al., 2014). This subgroup demonstrated the same trend seen in the overall HMB cohort, a disproportionate
rate of hospitalization based on income across all locations except the fringe metropolitan
areas, Figure 13. In the rural area, 75% of all hospitalizations were in the lowest median
income stratum.
Overall, the lowest income group were 2.5 times more likely to require
hospitalization than the highest income stratum, 37.8% versus the highest 15.0%, N =
342 and 136 respectively. The 22.8% difference between these two groups is significant
(p < 0.0001, 96% CI: 14.2% to 30.1%). Women in the lowest income stratum also appear
to have a more serious health phenotype. While the association of increasing age in
women, who present with anemia, supports the theory that delayed health-seeking
behavior increases the health burden, hospitalization is highest among the youngest
women, table 25. This trend to treat the younger women more aggressively may be due to
a treatment bias for younger women or be due to a lower threshold for interventions
based on age. The anemia sub-population follows the overall HMB cohort trend of a
health disadvantage being associated with their location (place).
Diabetes was explored as one of two determinants of overall health. Diabetes
represented a small segment of the HMB cohort, 0.75%. The analysis should be
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interpreted with caution due to the low statistical power. Based on the CDC (National
Diabetes Statistical Report – CDC, 2018) crude population prevalence estimate for
women aged 18 to 44 is 3.0% (95% CI: 2.6 to 3.6), this comorbidity appears to be
underrepresented. The incidence in the age groups 20-29, 30-39, and 40-49 were 1.37%,
1.78%, and 1.8% respectively approximately half of the expected rate. A possible
explanation could be that in the emergency department, the clinical focus on the primary
complaint may lead to a bias to not collect complete health information especially if
health factors are considered extraneous to the primary reason for presentation.
Additionally, if women do not report their complete health history and wish to focus on
the bleeding, health comorbidities such as diabetes may be under-reported.
Examination of Figure 14 reveals a similar trend observed in the overall HMB
cohort. Inferring differences between locations is not possible due to the very small
numbers in the smallest locations. The overall comparison between women in the lowest
median income group versus the highest was significant. The income lowest stratum
represented 36.2% (N = 64) of the women versus the highest-income 10.7% (N = 19).
The difference of 25.5% was significant, p = 0.035, 95% CI: 2.0 to 40). No other income
comparisons were statistically significant.
Diabetes
Diabetes was explored as one of two determinants of overall health. Diabetes
represented a small segment of the HMB cohort, 0.75%. The analysis should be
interpreted with caution due to the low statistical power. Based on the CDC (National
Diabetes Statistical Report – CDC, 2018) crude population prevalence estimate for
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women aged 18 to 44 is 3.0% (95% CI: 2.6 to 3.6), this comorbidity appears to be
underrepresented. The incidence in the age groups 20-29, 30-39 and 40-49 were 1.37%,
1.78%, and 1.8% respectively approximately half of the expected rate. A possible
explanation could be that in the emergency department, the clinical focus on the primary
complaint may lead to a bias to not collect complete health information especially if
health factors are considered extraneous to the primary reason for presentation.
Additionally, if women do not report their complete health history and wish to focus on
the bleeding, health comorbidities such as diabetes may be under-reported.
Examination of Figure 15 reveals a similar trend observed in the overall HMB
cohort. Inferring differences between locations is not possible due to the very small
numbers in the smallest locations. The overall comparison between women in the lowest
median income group versus the highest was significant. The income lowest stratum
represented 36.2% (N = 64) of the women versus the highest income 10.7% (N = 19).
The difference of 25.5% was significant, p = 0.035, 95% CI: 2.0 to 40). No other income
comparisons were statistically significant.
Hypertension
Hypertension was the second health determinant studied as potential comorbidity
that could also be associated with poor health-seeking behavior. Women with a
secondary diagnosis of hypertension represented 2.86% (N = 3,194) of the total HMB
population. The trend of increased hospitalization frequency among women with the
lowest median income persisted, Figure 16. At each location again except for fringe
metropolitan regions, women in the lowest income stratum were significantly more likely
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to be hospitalized. A woman with HMB and hypertension in the lowest income stratum
was 2.9 times more likely than the highest income group to be hospitalized. This
difference of 26.7% was significant, p < 0.001 95% CI: 19.0% to 33.2%. Consistent with
findings of the whole HMB cohort, the influence of the determinant income in women
with a secondary diagnosis of hypertension is associated with greater hospitalizations
regardless of place. Also, the poorest women in the smallest locations, rural and
micropolitan dominate hospitalizations.
Strengths and Limitations
The study was retrospective in design, involved creating an inception cohort from
the 2016 HCUP NEDS and NRD databases. The HCUP data is a secondary data source
and is limited to the data captured in the available record. This research used the case
definition for HMB based on The International Statistical Classification of Diseases and
Health Related Problems, ICD-10-CM/PCS codes. The primarily patient selection was
consequently dependent upon the case report classification by the attending physician.
Verification of the accuracy of the initial diagnosis is not possible, as patient
identification protection does not permit any form of back tracing of cases. The cases
thus extracted from the databases are considered valid as they were coded for HMB and
all associated hospital costs were paid for via Medicare, Medicaid, private insurance, or
out of pocket sources. The possibility of an inaccurate diagnosis of HMB, in any case,
cannot be ignored.
A woman entering the ED with the complaint of HMB will not be able to receive
a definitive test to confirm the historically accepted daily blood loss of greater than 80
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mL per menstrual cycle (Hallberg, & Nilsson, 1964). Thus, an attending physician will
rely primarily on the patient reported concern in classifying the primary diagnosis.
Subjective and self-reporting of blood loss may be considered a poor indicator of actual
menstrual loss. Quantifying monthly blood loss is challenging, precise reporting of blood
loss is more problematic (Moon et al., 2017). Evidence does indicate a positive
correlation with objectively measured blood loss (Quinn, & Higham, 2016). A caveat is
that the positive predictive value is low. The validity and strength of patient or selfreported events is gaining interest and credibility (O’Mahony et al., 2016). While
individual perceptions may be prone to high degrees of variability, patient’s reported
outcomes (PRO) data are useful when large sample sets are available to represent
community health (Begg et al., 2013). This research thus relied on the collected cases
based on the patient reported complaint of HMB. These limitations notwithstanding, PRO
data may contribute to a more complete and deeper understanding of the true population
burden and provide insights into the impact of living with a disease (O’Mahony et al.,
2016). Thus, the estimates of risk and determinants associated with HMB have a
reasonable level of evidence for public health consideration.
Understanding the population burden of HMB requires a large data sample to
provide evidence that is potentially externally valid. A key strength of the National
databases used is a large number of contributing centers. In the NEDS database where
111,555 HMB cases were extracted from 32,677,936 records, 953 hospital EDs from 36
states contributed data. This NEDS sample represented an approximately 20% stratified
sample of US hospital emergency departments. Weighted for National estimates, the
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number of ED visits represents approximately 144,842,742 visits. A strength of so-called
big data is the reduced variability and the influence of individual center effects (Kafadar,
2020). Additionally, with a large data set the violation of the independence of each event
is unlikely (Murray et al., 2020). While having greater visibility of the individual patient
record would be ideal, the ability to generate estimates of contributors to HMB
presentation in the ED is greatly facilitated by these large national data sources.
A limitation associated with secondary data is that the data fields collected are
defined by the lowest common denominator. This limitation illustrates that many of the
states do not report racial data. As a result, no racial data was available in this national
database. If an exploration of racial differences or disparities was to be pursued, only the
individual state databases that report race could be queried. Such an analysis would not
provide a national picture undermining the intent of this project. Another limitation of the
individual data provided was an absence of information on height and weight to allow for
BMI estimation. The Theory of Reasoned Action posits that women who exhibit
prolonged health avoidance behavior regarding their reproductive health to need ED
attention may also have other comorbidities such as a greater prevalence of obesity and
smoking. Unfortunately, these determinants as well as educational attainment were not
available.
Threats to Validity
The collection methods and input integrity of the HCUP data as a secondary data
source are important determinants of the quality of the findings. Thus, a key threat to
validity is to use data for research purposes for which they are not specifically generated
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(Kuriyama et al., 2017). The NEDS and NRD data were collected from contributing
hospitals. The rigor of the collection methods and accuracy has been demonstrated
through over a decade of collection. A primary element of the validity of these research
findings will be the accuracy of the disease status coded into the electronic records in
which rely on the categorical codes of ICD-10-CM/PCS. Studies that have compared
diagnoses and procedures reported in administrative data compared with medical records
have found acceptable levels of agreement (Casey et al., 2016). Hsu et al. (2014) found
that the positive predictive value (PPV) for the ICD-9 code 471.x for nasal polyps was
85%. This would support the premise that those with the diagnostic code do indeed have
the disease. More recent data on HMB bleeding where ICD-10 codes have been crossreferenced with the patient files support the premise that these secondary records can be
considered valid for the diagnoses categorized (Borzutsky, & Jaffray 2020).
Internal Validity
Generation of reliable risk estimates from the HCUP data will require addressing
bias, confounding, and random error as alternative explanations (Casey et al., 2016).
While large sizes reduce the bias due to random error, bias due to measurement error is
independent of sample size (Mooney et al., 2015). Estimation of measures of the
association has been quantified with 95% confidence intervals. Uses of hospital records
have limitations including data collection and misclassification bias. The ICD-10CM/PCS coding has to be assumed to be correct as there is no possibility of back tracing
patients to validate accuracy. Attrition bias is not expected to be a concern as each ED
presentation is recorded over 90% of cases were presented and released within one day.
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The motivation to seek care in the ED is theorized to be driven by high degrees of
symptom severity minimizing the attrition effects in individuals with access and also
strengthen the likelihood of accurate disease coding.
Several biases should be examined. Nonparticipation bias remains a concern as
this is expected to result in underestimation of the overall population problem, and
potentially skew the study population towards individuals with higher income,
educational attainment, and access to health care resources. Individuals who choose not
to seek care are theorized to have symptoms that may be deemed non-severe or having
minimal impact on the quality of life. The income distribution in the HMB cohort would
suggest that nonparticipation bias is limited, table 12. The lowest median household
income quartile ($1 – $42,999) represented 39.59% of the inception cohort, the greatest
proportion. The highest quartile (> $72,000) represented the smallest proportion of the
cohort, 13.29%. Recall bias is likely minimal as the data is generated by the extraction of
individual patient billing records collected at the time of ED presentation. Lastly,
statistical regression is likely minimal due to the large sample size. Confounding by
extraneous effects such as age and other factors such as medium income quartile,
location, and payer were examined and adjusted for. Confounding by indication and
severity are important. The presence of symptoms (indication) is the selection criteria for
inclusion. Each HMB event is coded and recorded with no context of individual impact
or health burden. A spectrum of severity of symptoms was captured in each ICD-10
coded event, with no ability to discriminate between benign and severe bleeding events.
This study used the criteria of hospital admission as a surrogate for either severe
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symptoms requiring additional complex management or a compromised health state that
requires additional support. In either case, hospital admission from the ED was
considered to represent severe or poor health status.
Random error due to inaccurate HMB classification was minimized. The cohort
was assessed by screening the study population data for errors such as a male being
coded for HMB. Elimination of records containing men presenting with HMB was done
to create the final study cohort. Additionally, the inception cohort only contained
reproductive age: older than 10 years on the bottom and below 65 years were on the top.
Interpretation of the analysis should keep in mind several limitations. First, the
data is sourced from administrative records and does not provide information on elements
that may influence outcomes such as resources within a hospital, staffing, protocols, and
the infrastructure. These inputs may contribute to the interventions utilized and
admission decisions. Detailed data on individual patient management are also not
available. This research cannot determine the overall health burden associated with HMB
presentation.
Generalizability
External validity is concerned with the degree to which an observed association
between an intervention and the reported results may be generalized to four distinct
domains of variation: people, interventions, outcomes, or settings (Huebschmann et al.,
2019). An important contributor to external validity is the representativeness of the
observed population and the settings of the study. This project was designed to explore
the ED as the setting for women who have found bleeding events to be either too severe
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or too frequent to be considered normal. Evidence suggests that the ED is often the place
of last resort for individuals who lack access to healthcare providers or who may be in an
acute crisis (Sardo et al., 2016). This study was not designed nor able to identify the root
causes or reasons for ED presentation. The methodology utilized was to collect HMB
ICD-10 coded cases, and describe, and estimate risks based on available data for this
inception cohort. How representative the women identified are for all women with HMB
is difficult to characterize.
From the studied inception cohort, women who were hospitalized for heavy
menstrual bleeding symptoms were older with a mean age of 40.77 years (SD 8.27). This
finding was consistent with a large study by Morrison (2008). Morrison et al. found that
women who were hospitalized for excessive bleeding had a mean age of 42 years. They
also reported that women between 25 to 50 years represented 85% of the study
population.
The generalizability of the findings should be interpreted with caution. The HMB
inception cohort is a sub-set of women who likely experience regular excessive monthly
bleeding. The reported median age was 29.00 years (standard deviation of 10.37 years,
figure 4) interquartile range 16 years (IQR = 21 – 37). The positive skewing suggests that
many of the women who present at the ED are in the younger range of their reproductive
years. Women from the lowest income stratum dominated this cohort. They were equally
likely to have Medicare or private insurance. A claims-based retrospective study of
idiopathic (no underlying condition identified) HMB women who were enrolled in a large
US health plan, extracted 21,362 women with a mean age of 39.42 (SD 6.78) years
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(Copher et al., 2013). Thus, women with access to healthcare may be able to receive
supportive treatment in the early years and delay symptoms that are more serious until
later years. This would suggest that the younger cohort of women who use the ED might
not have healthcare options in the early reproductive years available to those with health
care insurance. The generalizability of this HMB cohort to the entire population may
need to be held in the context of both access to healthcare (insurance status) and income.
Both of these determinants are related.
A notable gap in the secondary data set is the absence of information on any other
care associated with the primary diagnosis. Women who find that the ED is their refuge
for a bleeding event perceived as excessive are not expected to have routine access to
gynecological or expert care. HMB cases present frequently in gynecology offices
(Davis, & Kadir, 2017). Such cases with access to health care would likely be attended to
in the physician’s office or clinic. The HCUP databases do not capture such visits. These
HMB visits collected in NEDS and NRD will be limited to those seeking attention in an
ED and thus represent women with either limited resources or inadequate access to
specialized care. The study sample thus represents the more serious or troublesome HMB
events and should be considered as an estimate of the more serious bleeding events in the
community, thus limiting the external validity of these findings. Mild bleeding events are
theorized to not reach a sufficient threshold to initiate a health-seeking behavior and thus
remain undetected.
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Public Health Concern
Women who present with complaints associated with excessive menstrual
bleeding may represent a group who suffer in silence. This research project was designed
to take the observations from the HCUP databases NEDS and NRD and translate them to
communities, T4. While the results presented from the inception cohort provide a
national perspective, the findings of morbidity and burden are from individual women
thus supporting the adage and reminding one that all public health is local (Green et al.,
2020). From the extraction of HMB cases and the national weighting, an estimated half a
million women (509,833) nationally present at emergency departments for heavy
menstrual bleeding. Of these presentations, 6.74% require admission to the hospital
(34,344). Many of these women (39.59%) come from households with the lowest median
income quartile of less than $43K per annum, supporting the theory that the ED is for
many women a healthcare refuge. The findings from this research quantify the
considerable public health issue associated with this silent burden.
Quantification of the burden of disease is limited to the associated hospital
charges. Based on the hospital charges (Table 13) for each HMB presentation, the
estimated national cost impact is in the range of $1.7 billion annually. The psychological
weight and consequences for each woman not available from this data. The Theory of
Reasoned Action posits that a woman who presents in the ED with HMB may be
initiating health-seeking behavior for many reasons. The perceptual framework of
reproductive health is complex. Health-related challenges might range from personal
restrictions that lead to work interruptions, reduced educational attainment, and self-
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limiting socialization. A recent qualitative study on the impact of HMB in adolescent
girls (aged 13-19) identified several themes of importance. The coordination of
healthcare visits, coping day-to-day, school attendance, and the need for information (Li
et al., 2020). Interviews with their parents recognized four important themes from the
interviews: (1) interactions with healthcare providers, (2) a need for greater information
on reproductive biology, (3) support and acceptance that the concerns are real, and (4) the
financial impact from repeated healthcare visits (Bellis, et al. 2020). These reports
coupled with the estimated cost impact support the finding that the public health burden
associated with HMB may be underestimated.
From a social change perspective, patients who are compelled to seek treatment
at an emergency department represent a cohort who have most likely found symptoms to
be persistent or acutely problematic beyond their perceptual norm. These presentations at
the ED must be recognized as serious in nature. The number of women presenting with a
single diagnosis was 28.4%, Figure 5. The converse is that 71.6% of the women had
more than one comorbidity diagnosed at presentation. This finding further adds context to
the health burden that is associated with HMB and would be expected from women who
have delayed seeking health. From a public health perspective, the argument for paid sick
leave may reduce the need for ED presentation. Schneider (2020) showed that employees
without sick leave are more likely to forgo needed medical care. Such delays in seeking
health care are expected to exacerbate existing conditions and lead to more consumption
of health care resources.
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Estimation of a significant risk for hospitalization for age by the logistic
regression model supports the theory of accumulating burden of reproductive life. This is
not proof of a causal association. These findings from secondary data should be
interpreted with caution, and be considered hypothesis-generating. This inception cohort
may best represent women who due to circumstances of delayed health-seeking behavior
have turned to the ED department for a health crisis. Additionally, this use of the ED may
be a feature of the US medical healthcare model and not generalizable to countries with
comprehensive care and greater access to specialized care. The reported HMB events as
coded by ICD-10 categorization is considered a useful indicator of a true HMB event.
Thus estimation of risk and cohort descriptive statistics allow for a characterization of the
public health burden associated with unattended HMB in the community.
HMB may have several potential causes and downstream consequences. Beyond
the rising risk of more profound anemia, hospitalization, psychosocial and quality of life
effects, other elements of reproductive health may also be affected (Yu et al., 2020).
Maternal mortality has been described as a crisis in the US (Mullen, 2020). In 1986
according to the CDC, seven women died during childbirth for every 100,000 live births
(Cohen, 1987). In 2016, the number has increased to 17 per 100,000 live births.
Examining the two periods of highest maternal risk for death: day of delivery and days
one to six postpartum, the number one cause of death during both times is hemorrhage,
24%, and 18% respectively (Mullen, 2020). While the data is not available, a suspicion
that many of these women may have had HMB symptoms in early life seems reasonable.
Further evidence supporting the theory that HMB is a sentinel event indicating potential
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underlying health issues is found in a report by Zia et al. (2020). Their prospective study
followed 235 consecutive postmenarchal adolescents who were referred to a bleeding
disorders clinic for HMB. Of these referrals, 33% were diagnosed with a bleeding
disorder. The authors found a high prevalence of a blood disorder independent of the
bleeding pattern. Of these adolescents who presented at the ED, 55% presented with
anovulatory bleeding which was considered difficult to manage. Additionally,
adolescents who presented at the ED were more likely to be hospitalized (OR = 2.03, p =
0.072) and more likely to need intravenous iron.
Beyond addressing the immediate medical and psychosocial needs of these
women, there is the issue of pedigree. Often the delayed health-seeking behavior is due to
a familial phenotype (Powers et al, 2018). If related family members also miss school or
work due to HMB, then an acceptance of this pattern as being perceived as normal is
likely. The big picture goal in identifying and characterizing this inception cohort is to
raise awareness of the frequency of HMB presentation in hospital emergency
departments. With this quantification of the HMB burden, public health may be able to
consider how to reduce the population burden. Moving forward, precision medicine
approaches become more commonly integrated into public health and health care
delivery systems (Ramaswami et al., 2018). Identifying bleeding disorders such as von
Willebrand disease or platelet dysfunctions should be considered when bleeding history
is suggestive. Women with HMB should not be simply discharged from the ED with
potentially very few therapeutic options such as hormonal therapy or oral contraceptives.
Identifying family linkages and ensuring that a history of unattended excessive bleeding
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is not considered normal reproductive health and consequently ignored by healthcare
providers is one long-term goal of this project.
Conclusions
Analysis of an inception cohort of 111,555 women who presented to the
emergency department with heavy menstrual bleeding symptoms revealed a prevalence
of women from low median income households who were more likely to be hospitalized
as they aged. For these women who are theorized to delay health-seeking behavior, those
in the smallest population locations were at greatest risk for hospitalization. This project
did not attempt to assign causality but did estimate associated risk using the health
determinants available from the HCUP databases accessed. The findings reported a need
to be examined prospectively to confirm the role of location, economic status, and
explore the contribution of racial background, educational attainment, and more robust
health surrogates such as body mass index.
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Appendix A: SPSS Programing Code for Data Extraction
SPSS Code for Whole Heavy Menstrual Bleeding Cohort from NEDS Database
GET
FILE='C:\Users\Henry\Documents\PhD\PhD Project\HCUP Database\NEDS
2016\NEDS_2016 (2)\NEDS 2016 HMB Data Set\NEDS Data 2016 HMB Core Data
SET Feb20.sav'.
DATASET NAME DataSet1 WINDOW=FRONT.
USE ALL.
COMPUTE filter_$=((I10_DX1 = "N920" OR I10_DX1 = "N921" OR I10_DX1 =
"N922" OR I10_DX1 = "N923" OR
I10_DX1 = "N924" OR I10_DX1 = "N925" OR I10_DX1 = "N926" OR I10_DX1
= "N930" OR I10_DX1 = "N938" OR
I10_DX1 = "N939") AND (AGE >= 10 AND AGE <= 60)).
VARIABLE LABELS filter_$ '(I10_DX1 = "N920" OR I10_DX1 = "N921" OR
I10_DX1 = "N922" OR I10_DX1 = '+
'"N923" OR I10_DX1 = "N924" OR I10_DX1 = "N925" OR I10_DX1 = "N926"
OR I10_DX1 = "N930" OR '+
'I10_DX1 = "N938" OR I10_DX1 = "N939") AND (AGE >= 10 AND AGE <=
60) (FILTER)'.
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'.
FORMATS filter_$ (f1.0).
FILTER BY filter_$.
EXECUTE.
EXAMINE VARIABLES=AGE Pay1
/PLOT BOXPLOT STEMLEAF HISTOGRAM NPPLOT
/COMPARE GROUPS
/STATISTICS DESCRIPTIVES
/CINTERVAL 95
/MISSING LISTWISE
/NOTOTAL.
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SPSS Code for Logistic Regression Model
GET
FILE='C:\Users\Henry\Documents\PhD\PhD Project\Chapter 4 Results\Logistic Regression
Analysis\Logistic Regression Model File\Core Date Fromated Files\NRD 2016 Core Data HMB
Logit April 20.sav'.
DATASET NAME DataSet1 WINDOW=FRONT.
DATASET ACTIVATE DataSet1.
SAVE OUTFILE='C:\Users\Henry\Documents\PhD\PhD Project\Chapter 4 Results\Logistic
Regression '+
'Analysis\Logistic Regression Model File\Core Date Fromated Files\NRD 2016 Core Data
HMB Logit '+
'April 20.sav'
/COMPRESSED.
GET
FILE='C:\Users\Henry\Documents\PhD\PhD Project\Chapter 4 Results\Logistic Regression
Analysis\Logistic Regression Model File\Core Date Fromated Files\NEDS 2016 Core Data HMB
Logit April 20.sav'.
DATASET NAME DataSet2 WINDOW=FRONT.
DATASET ACTIVATE DataSet2.
SAVE OUTFILE='C:\Users\Henry\Documents\PhD\PhD Project\Chapter 4 Results\Logistic
Regression '+
'Analysis\Logistic Regression Model File\Core Date Fromated Files\NEDS 2016 Core Data
HMB '+
'Logit April 20.sav'
/COMPRESSED.
DATASET ACTIVATE DataSet1.
DATASET ACTIVATE DataSet1.
SAVE OUTFILE='C:\Users\Henry\Documents\PhD\PhD Project\Chapter 4 Results\Logistic
Regression '+
'Analysis\Logistic Regression Model File\Core Date Fromated Files\NRD 2016 Core Data
HMB Logit '+
'April 20.sav'
/COMPRESSED.
DATASET ACTIVATE DataSet1.
SAVE OUTFILE='C:\Users\Henry\Documents\PhD\PhD Project\Chapter 4 Results\Logistic
Regression '+
'Analysis\Logistic Regression Model File\Core Date Fromated Files\NRD 2016 Core Data
HMB Logit '+
'April 20.sav'
/COMPRESSED.
DATASET ACTIVATE DataSet2.
ADD FILES /FILE=*
/FILE='DataSet1'.
EXECUTE.
USE ALL.
COMPUTE filter_$=((I10_DX1 = "N939" OR I10_DX1 = "N938" OR I10_DX1 = "N930" OR I10_DX1 =
"N926" OR
I10_DX1 = "N925" OR I10_DX1 = "N924" OR I10_DX1 = "N923" OR I10_DX1 = "N922" OR
I10_DX1 = "N921" OR
I10_DX1 = "N920") AND (AGE >= 10 AND AGE <= 60) ).
VARIABLE LABELS filter_$ '(I10_DX1 = "N939" OR I10_DX1 = "N938" OR I10_DX1 = "N930" OR
I10_DX1 = '+
'"N926" OR I10_DX1 = "N925" OR I10_DX1 = "N924" OR I10_DX1 = "N923" OR I10_DX1 =
"N922" OR '+
'I10_DX1 = "N921" OR I10_DX1 = "N920") AND (AGE >= 10 AND AGE <= 60) (FILTER)'.
VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'.
FORMATS filter_$ (f1.0).
FILTER BY filter_$.
EXECUTE.
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